<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD v1.1 20151215//EN" "JATS-archivearticle1.dtd"> 
<article xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="research-article"><?properties open_access?><?DTDIdentifier.IdentifierValue -//Atypon//DTD Atypon Systems Journal Archiving and Interchange NLM DTD v3.0.6 20130326//EN?><?DTDIdentifier.IdentifierType public?><?SourceDTD.DTDName atypon-archivearticle3.dtd?><?SourceDTD.Version 3.0.6?><?ConverterInfo.XSLTName atyponoasis-oasisns2nlmx2.xsl?><?ConverterInfo.Version 2?><front><journal-meta><journal-id journal-id-type="nlm-ta">Antioxid Redox Signal</journal-id><journal-id journal-id-type="iso-abbrev">Antioxid. Redox Signal</journal-id><journal-id journal-id-type="publisher-id">ars</journal-id><journal-title-group><journal-title>Antioxidants &#x00026; Redox Signaling</journal-title></journal-title-group><issn pub-type="ppub">1523-0864</issn><issn pub-type="epub">1557-7716</issn><publisher><publisher-name>Mary Ann Liebert, Inc.</publisher-name><publisher-loc>140 Huguenot Street, 3rd FloorNew Rochelle, NY 10801USA</publisher-loc></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">4971421</article-id><article-id pub-id-type="pmid">27306612</article-id><article-id pub-id-type="publisher-id">10.1089/ars.2015.6560</article-id><article-id pub-id-type="doi">10.1089/ars.2015.6560</article-id><article-categories><subj-group subj-group-type="heading"><subject>Original Research Communications</subject></subj-group></article-categories><title-group><article-title>Redox-Dependent Modulation of T-Type Ca<sup>2+</sup> Channels in Sensory Neurons Contributes to Acute Anti-Nociceptive Effect of Substance P</article-title></title-group><contrib-group><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Dongyang</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Huang</surname><given-names>Sha</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Gao</surname><given-names>Haixia</given-names></name><xref ref-type="aff" rid="aff1"><sup>1,</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Liu</surname><given-names>Yani</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Qi</surname><given-names>Jinlong</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Chen</surname><given-names>Pingping</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Wang</surname><given-names>Caixue</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author"><name><surname>Scragg</surname><given-names>Jason L.</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Vakurov</surname><given-names>Alexander</given-names></name><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><contrib contrib-type="author"><name><surname>Peers</surname><given-names>Chris</given-names></name><xref ref-type="aff" rid="aff3"><sup>3</sup></xref></contrib><contrib contrib-type="author"><name><surname>Du</surname><given-names>Xiaona</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Zhang</surname><given-names>Hailin</given-names></name><xref ref-type="aff" rid="aff1"><sup>1</sup></xref></contrib><contrib contrib-type="author" corresp="yes"><name><surname>Gamper</surname><given-names>Nikita</given-names></name><xref ref-type="aff" rid="aff1"><sup>1,</sup></xref><xref ref-type="aff" rid="aff2"><sup>2</sup></xref></contrib><aff id="aff1"><label><sup>1</sup></label>Department of Pharmacology, <institution>Hebei Medical University</institution>, Shijiazhuang, <country>P.R. China</country>.</aff><aff id="aff2"><label><sup>2</sup></label>School of Biomedical Sciences, Faculty of Biological Sciences, <institution>University of Leeds</institution>, Leeds, <country>United Kingdom</country>.</aff><aff id="aff3"><label><sup>3</sup></label>Leeds Institute of Cardiovascular and Metabolic Medicine (LICAMM), Faculty of Medicine and Health, <institution>University of Leeds</institution>, Leeds, <country>United Kingdom</country>.</aff></contrib-group><author-notes><corresp><addr-line>Address correspondence to:</addr-line><addr-line><italic>Prof. Hailin Zhang</italic></addr-line><addr-line><italic>Department of Pharmacology</italic></addr-line><institution><italic>Hebei Medical University</italic></institution><addr-line><italic>050011 Shijiazhuang</italic></addr-line><country>P.R. China</country><break/><italic>E-mail:</italic><email xlink:href="mailto:zhanghl@hebmu.edu.cn">zhanghl@hebmu.edu.cn</email></corresp><corresp><addr-line><italic>Prof. Nikita Gamper</italic></addr-line><addr-line><italic>School of Biomedical Sciences</italic></addr-line><addr-line><italic>Faculty of Biological Sciences</italic></addr-line><institution><italic>University of Leeds</italic></institution><addr-line><italic>LS2 9JT Leeds</italic></addr-line><country>United Kingdom</country><break/><italic>E-mail:</italic><email xlink:href="mailto:n.gamper@leeds.ac.uk">n.gamper@leeds.ac.uk</email></corresp></author-notes><pub-date pub-type="ppub"><day>10</day><month>8</month><year>2016</year><!--string-date: August 10, 2016--></pub-date><pub-date pub-type="epub"><day>01</day><month>8</month><year>2016</year></pub-date><pub-date pub-type="pmc-release"><day>01</day><month>8</month><year>2016</year></pub-date><!-- PMC Release delay is 0 months and 0 days and was based on the <pub-date pub-type="epub"/>. --><volume>25</volume><issue>5</issue><fpage>233</fpage><lpage>251</lpage><history><date date-type="received"><day>30</day><month>10</month><year>2015</year><!--string-date: Date of first submission to ARS Central, October 30, 2015--></date><date date-type="rev-recd"><day>26</day><month>5</month><year>2016</year><!--string-date: date of final revised submission, May 26, 2016--></date><date date-type="accepted"><day>14</day><month>6</month><year>2016</year><!--string-date: date of acceptance, June 14, 2016--></date></history><permissions><copyright-statement>&#x000a9; Dongyang Huang et al. 2016; Published by Mary Ann Liebert, Inc.</copyright-statement><copyright-year>2016</copyright-year><license license-type="open-access"><license-p>This Open Access article is distributed under the terms of the Creative Commons License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/4.0">http://creativecommons.org/licenses/by/4.0</ext-link>), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited.</license-p></license></permissions><self-uri content-type="pdf" xlink:type="simple" xlink:href="ars.2015.6560.pdf"/><abstract><title>Abstract</title><p><bold><italic>Aims:</italic></bold> Neuropeptide substance P (SP) is produced and released by a subset of peripheral sensory neurons that respond to tissue damage (nociceptors). SP exerts excitatory effects in the central nervous system, but peripheral SP actions are still poorly understood; therefore, here, we aimed at investigating these peripheral mechanisms. <bold><italic>Results:</italic></bold> SP acutely inhibited T-type voltage-gated Ca<sup>2+</sup> channels in nociceptors. The effect was mediated by neurokinin 1 (NK1) receptor-induced stimulation of intracellular release of reactive oxygen species (ROS), as it can be prevented or reversed by the reducing agent dithiothreitol and mimicked by exogenous or endogenous ROS. This redox-mediated T-type Ca<sup>2+</sup> channel inhibition operated through the modulation of Ca<sub>V</sub>3.2 channel sensitivity to ambient zinc, as it can be prevented or reversed by zinc chelation and mimicked by exogenous zinc. Elimination of the zinc-binding site in Ca<sub>V</sub>3.2 rendered the channel insensitive to SP-mediated inhibition. Importantly, peripherally applied SP significantly reduced bradykinin-induced nociception in rats <italic>in vivo</italic>; knock-down of Ca<sub>V</sub>3.2 significantly reduced this anti-nociceptive effect. This atypical signaling cascade shared the initial steps with the SP-mediated augmentation of M-type K<sup>+</sup> channels described earlier. <bold><italic>Innovation:</italic></bold> Our study established a mechanism underlying the peripheral anti-nociceptive effect of SP whereby this neuropeptide produces ROS-dependent inhibition of pro-algesic T-type Ca<sup>2+</sup> current and concurrent enhancement of anti-algesic M-type K<sup>+</sup> current. These findings will lead to a better understanding of mechanisms of endogenous analgesia. <bold><italic>Conclusion:</italic></bold> SP modulates T-type channel activity in nociceptors by a redox-dependent tuning of channel sensitivity to zinc; this novel modulatory pathway contributes to the peripheral anti-nociceptive effect of SP. <italic>Antioxid. Redox Signal</italic>. 25, 233&#x02013;251.</p></abstract><counts><fig-count count="11"/><equation-count count="2"/><ref-count count="76"/><page-count count="19"/></counts></article-meta></front><body><sec sec-type="intro" id="s001"><title>Introduction</title><p>S<sc>ubstance</sc> P (SP) <sc>is an</sc> 11-amino-acid neuropeptide (RPKPQQFFGLM) of a tachykinin family that is produced in both peripheral and central nervous systems (CNS). SP is mainly an excitatory neuromodulator that is involved in pain transmission and smooth muscle contraction, and it modulates inflammatory and immune responses (<xref rid="B69" ref-type="bibr">69</xref>). Increased SP release or elevated expression of its receptors has been linked to many diseases such as acute and chronic inflammation and infections, asthma, affective and addictive disorders, and some forms of cancer [reviewed in Steinhoff <italic>et al</italic>. (<xref rid="B62" ref-type="bibr">62</xref>)]. In the peripheral somatosensory system, SP is abundantly produced by a subset of transient receptor potential cation channel subfamily V member 1 (TRPV1)-positive, pain-sensing (nociceptive) neurons and released in response to noxious stimulation both centrally and peripherally (<xref rid="B40" ref-type="bibr">40</xref>).</p><p>Peripheral SP released from nociceptive nerve endings causes so-called &#x0201c;neurogenic inflammation&#x0201d; (<xref rid="B54" ref-type="bibr">54</xref>); whereas in the spinal cord, SP functions as an excitatory co-transmitter alongside glutamate (<xref rid="B12" ref-type="bibr">12</xref>, <xref rid="B38" ref-type="bibr">38</xref>). Intracellular effects of SP are mediated by the G-protein-coupled neurokinin (NK1&#x02009;&#x02212;&#x02009;3) receptors. The strong excitatory role of SP in spinal nociceptive pathways has triggered a massive, industry-wide quest for new analgesics based on NK1 receptor antagonists. However, despite strong pre-clinical data, clinical trials of NK1 receptor antagonists failed (<xref rid="B22" ref-type="bibr">22</xref>, <xref rid="B59" ref-type="bibr">59</xref>).</p><boxed-text position="float" orientation="portrait"><label>Innovation</label><p>We discovered a novel endogenous pathway of &#x0201c;tuning&#x0201d; the activity of T-type Ca<sup>2+</sup> channels <italic>via</italic> the modulation of its sensitivity to ambient zinc. We further suggest that simultaneous reciprocal modulation of two different ion channels by a single signaling cascade can sum up to produce a cumulative, endogenous anti-nociceptive effect. These findings describe and explain an unanticipated inhibitory effect of neuropeptide substance P (SP) in peripheral nociceptive pathways and shed new light on the mechanisms of endogenous analgesia.</p></boxed-text><p>The reasons for the lack of analgesic efficacy of the systemically applied NK antagonists are still unclear. However, one hypothesis is that, though excitatory in CNS, SP may exert paradoxical inhibitory/analgesic effects in the peripheral nociceptive pathways (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>). Thus, SP augments an inhibitory M-type K<sup>+</sup> current in nociceptors <italic>via</italic> the atypical G<sub>i/o</sub>-mediated signaling cascade that utilizes reactive oxygen species (ROS) as second-messenger molecules (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>).</p><p>Here, we discovered another component of the anti-excitatory action of SP in nociceptors: inhibition of T-type (Ca<sub>V</sub>3) Ca<sup>2+</sup> channels. Ca<sub>V</sub>3 are encoded by <italic>CACNA1G, CACNA1H</italic>, and <italic>CACNA1I</italic> genes, which give rise to Ca<sub>V</sub>3.1, Ca<sub>V</sub>3.2, and Ca<sub>V</sub>3.3 pore-forming &#x003b1; subunits, respectively (<xref rid="B8" ref-type="bibr">8</xref>). T-type channels are activated at voltages near or below &#x02212;60&#x02009;mV and may display a significant window current at the neuronal resting membrane potential (E<sub>rest</sub>) (<xref rid="B51" ref-type="bibr">51</xref>). Ca<sub>V</sub>3s are abundantly expressed in cell bodies, axons, and peripheral terminals of nociceptive dorsal root ganglia (DRG) neurons, with Ca<sub>V</sub>3.2 being the dominant isoform (<xref rid="B9" ref-type="bibr">9</xref>, <xref rid="B11" ref-type="bibr">11</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B56" ref-type="bibr">56</xref>, <xref rid="B63" ref-type="bibr">63</xref>). Accordingly, peripherally applied T-type channel inhibition produces anti-nociceptive effects (<xref rid="B2" ref-type="bibr">2</xref>, <xref rid="B65" ref-type="bibr">65</xref>).</p><p>Here, we show that (i) SP acutely inhibits T-type Ca<sup>2+</sup> channels in DRG neurons <italic>via</italic> an ROS-dependent intracellular signaling cascade; (ii) this redox-mediated inhibition operates through the modulation of Ca<sub>V</sub>3.2 channel sensitivity to ambient extracellular zinc; and (iii) a hind-paw injection of SP produces anti-nociceptive effects that can be reduced by the <italic>in vivo</italic> knock-down of Ca<sub>V</sub>3.2 in DRG and partially mimicked by the peripheral injection of a specific T-type channel blocker. Thus, our study establishes a dual mechanism by which SP exerts its peripheral anti-nociceptive effect: a simultaneous inhibition of excitatory T-type Ca<sup>2+</sup> current and an enhancement of inhibitory M-type K<sup>+</sup> current.</p></sec><sec sec-type="results" id="s002"><title>Results</title><sec id="s003"><title>SP inhibits T-type Ca<sup>2+</sup> current in sensory neurons <italic>via</italic> endogenous ROS generation</title><p>SP has been shown to trigger endogenous ROS release in nociceptive DRG neurons in an &#x0201c;atypical&#x0201d; G<sub>i/o</sub>-mediated signaling cascade stimulating mitochondrial ROS generation (<xref rid="B33" ref-type="bibr">33</xref>). Since T-type Ca<sup>2+</sup> channels are expressed in nociceptors and are redox sensitive (<xref rid="B49" ref-type="bibr">49</xref>, <xref rid="B65" ref-type="bibr">65</xref>), we investigated whether SP affects the activity of low-voltage-activated (LVA, T-type) Ca<sup>2+</sup> currents in DRG neurons.</p><p>Whole-cell recordings were made from cultured, small-diameter, and mostly TRPV1-positive neurons. In 301 of 710 (42%) such DRG neurons, depolarization to &#x02212;40&#x02009;mV induced LVA currents, with kinetic properties similar to those of recombinant Ca<sub>V</sub>3.2 (<xref ref-type="fig" rid="f1">Fig. 1A<sub>1</sub></xref>
<italic>cf.</italic>
<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1A<sub>1</sub></xref>; Supplementary Data are available online at <uri xlink:type="simple" xlink:href="http://www.liebertpub.com/ars">www.liebertpub.com/ars</uri>). These currents were sensitive to the selective T-type Ca<sup>2+</sup>-channel inhibitor, N-[[1-[2-(tert-butylamino)-2-oxoethyl]piperidin-4-yl]methyl]-3-chloro-5-fluorobenzamide (Z944; 1&#x02009;&#x003bc;<italic>M</italic>; <xref ref-type="fig" rid="f1">Fig. 1A<sub>1</sub>&#x02013;A<sub>3</sub></xref>), and the voltage-gated Ca<sup>2+</sup> channel (VGCC) inhibitor mibefradil (MIB, 3&#x02009;&#x003bc;<italic>M</italic>; <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1A<sub>1</sub>&#x02013;D<sub>1</sub></xref>). In our earlier experiments, we used MIB to confirm current identity but later switched to Z944, when it became available.</p><fig id="f1" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 1.</bold></label><caption><p><bold>NK1 receptor activation inhibits T-type calcium channels in small-diameter DRG neurons.</bold> All recordings were performed from small (&#x0223c;20&#x02009;&#x003bc;m) DRG neurons with a mean whole-cell capacitance of 23.0&#x02009;&#x000b1;&#x02009;0.9 pF (<italic>n</italic>&#x02009;=&#x02009;100); these neurons are predominantly (&#x0223c;70%) capsaicin sensitive (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B35" ref-type="bibr">35</xref>). <bold>(A)</bold> LVA Ca<sup>2+</sup> current in DRG neurons is inhibited by an NK1-selective agonist S9SP. <bold>(A<sub>1</sub>)</bold> Example time course of the effects of 1&#x02009;&#x003bc;<italic>M</italic> S9SP and 1&#x02009;&#x003bc;<italic>M</italic> selective T-type channel inhibitor, Z944 on the LVA Ca<sup>2+</sup> current recorded from small-diameter DRG neurons using whole-cell patch clamp. Plotted are peak LVA current amplitudes; periods of drug application are indicated by the <italic>vertical gray bars</italic>. <italic>Inset</italic> shows example current traces; current protocol is depicted above the traces. <bold>(A<sub>2</sub>)</bold> Similar to <bold>(A<sub>1</sub>)</bold> but 1&#x02009;&#x003bc;<italic>M</italic> S9SP was co-applied with the 3&#x02009;&#x003bc;<italic>M</italic> selective NK1 antagonist CP-99994 (after 30 min pre-incubation with the latter). <bold>(A<sub>3</sub>)</bold> Similar to <bold>(A<sub>1,</sub> A<sub>2</sub>)</bold> but another selective NK1 agonist, S9M11SP (1&#x02009;&#x003bc;<italic>M</italic>) was applied instead of S9SP. <bold>(B)</bold> Scatter plot summarizing the experiments exemplified in <bold>(A<sub>1</sub>&#x02013;A<sub>3</sub>)</bold>. Each <italic>circle</italic> represents LVA current inhibition in a single neuron; the number of individual recordings is given above each group; <italic>horizontal gray bars</italic> are mean values for each group. ***Significantly different from the S9SP group, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 (unpaired <italic>t</italic>-test). <bold>(C)</bold> Example experiment <bold>(C<sub>1</sub>)</bold> and summary <bold>(C<sub>2</sub>)</bold> of the experiments showing concentration dependency of the LVA current inhibition by S9SP in DRG neurons. Increasing concentrations of S9SP were applied during the periods indicated by <italic>horizontal black bars</italic>. <bold>(C<sub>2</sub>)</bold> The data from eight to nine experiments as in <bold>(C<sub>1</sub>)</bold> were fit to the one-component logistic function (see <xref ref-type="sec" rid="s008">Materials and Methods</xref> section). Data are given as mean&#x02009;&#x000b1;&#x02009;SEM. CP-99994, (2S,3S)-3-(2-Methoxybenzylamino)-2-phenylpiperidine dihydrochloride; DRG, dorsal root ganglion; LVA, low-voltage activated; NK1, neurokinin 1; S9M11SP, [Sar<sup>9</sup>, Met(O<sub>2</sub>)<sup>11</sup>]-Substance P; S9SP, [Sar<sup>9</sup>]-Substance P; SEM, standard error of the mean; Z944, N-[[1-[2-(tert-butylamino)-2-oxoethyl]piperidin-4-yl]methyl]-3-chloro-5-fluorobenzamide.</p></caption><graphic xlink:href="fig-1"/></fig><p>The mean LVA current amplitude was &#x02212;161.7&#x02009;&#x000b1;&#x02009;11.3 pA. The NK1-specific agonist [Sar<sup>9</sup>]-Substance P (S9SP; 1&#x02009;&#x003bc;<italic>M</italic>) acutely inhibited LVA current in the majority of the LVA-expressing DRG neurons (<xref ref-type="fig" rid="f1">Fig. 1A<sub>1</sub>, B</xref>); the mean inhibition was 22.5%&#x02009;&#x000b1;&#x02009;2.3% (<italic>n</italic>&#x02009;=&#x02009;84; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001), although there was a degree of scattering in the magnitude of a response and approximately a third of neurons tested displayed minimal response (<italic>e.g.</italic>, 28/84 or 33% neurons had &#x0003c;10% inhibition), which was suggestive of a low level of NK1 receptor expression in these neurons.</p><p>Analysis of the concentration dependency of S9SP effects (<xref ref-type="fig" rid="f1">Fig. 1C</xref>) revealed that SP inhibited LVA current in DRG neurons, with IC<sub>50</sub> of 6.2&#x02009;&#x000b1;&#x02009;3.0&#x02009;n<italic>M</italic> and maximal inhibition of 59.2%&#x02009;&#x000b1;&#x02009;4.2% (<italic>n</italic>&#x02009;=&#x02009;8&#x02013;9). NK1-selective antagonist (2S,3S)-3-(2-Methoxybenzylamino)-2-phenylpiperidine dihydrochloride (CP-99994) abolished the effect of S9SP (<xref ref-type="fig" rid="f1">Fig. 1A<sub>2</sub>, B</xref>). Another NK1-selective agonist, [Sar<sup>9</sup>, Met(O<sub>2</sub>)<sup>11</sup>]-Substance P (S9M11SP; 1&#x02009;&#x003bc;<italic>M</italic>) produced LVA current inhibition quantitatively similar to that of S9SP (<xref ref-type="fig" rid="f1">Fig. 1A<sub>3</sub>, B</xref>).</p><p>Although NK1 receptor signaling is generally associated with the G<sub>q/11</sub> type of signaling cascade (<xref rid="B37" ref-type="bibr">37</xref>, <xref rid="B43" ref-type="bibr">43</xref>), recent data suggest that at least some effects of SP in DRG neurons, such as ROS release and redox-dependent M channel augmentation, occur <italic>via</italic> the G<sub>i/o</sub>-associated pathway (<xref rid="B33" ref-type="bibr">33</xref>). To test which signaling cascade is used in the S9SP-mediated inhibition of LVA current in DRG neurons, we used small interfering RNA (siRNA) knock-down of either G<sub>i/o</sub> or G<sub>q/11</sub> G&#x003b1; subunits in DRG cultures (<xref ref-type="fig" rid="f2">Fig. 2A</xref>). Simultaneous knock-down of G<sub>i1&#x02013;3</sub> and G<sub>o</sub> subunits abolished the S9SP-mediated LVA current inhibition, whereas simultaneous knock-down of G<sub>q</sub> and G<sub>11</sub> subunits was without an effect (as compared with non-targeting &#x0201c;scrambled&#x0201d; siRNA control; <xref ref-type="fig" rid="f2">Fig. 2A, B</xref>). All siRNA oligos reduced the abundance of their corresponding target messenger RNA (mRNA) by 60%&#x02013;80% (<xref ref-type="fig" rid="f2">Fig. 2C</xref>).</p><fig id="f2" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 2.</bold></label><caption><p><bold>NK1 receptors inhibit LVA currents in DRG neurons using a G<sub>i/o</sub>-mediated signaling cascade. (A)</bold> Example time courses of the effects of S9SP in DRG neurons where either G<sub>i</sub> and G<sub>o</sub>
<bold>(A<sub>2</sub>)</bold> or G<sub>q</sub> and G<sub>11</sub>
<bold>(A<sub>3</sub>)</bold> G&#x003b1; subunits were knocked down using siRNA cocktails (see <xref ref-type="sec" rid="s008">Materials and Methods</xref> section). Non-targeting &#x0201c;scrambled&#x0201d; siRNA oligonucleotides were used as negative control <bold>(A<sub>1</sub>)</bold>. <bold>(B)</bold> Scatter plot summarizing the experiments exemplified in <bold>(A<sub>1</sub>&#x02013;A<sub>3</sub>)</bold>. Each <italic>circle</italic> represents LVA current inhibition in a single neuron; the number of individual recordings is given above each group; <italic>horizontal gray bars</italic> are mean values for each group. <bold>(C)</bold> Quantification of knock-down efficiency 48&#x02009;h post-transfection from experiments as these shown in <bold>(A, B)</bold>. Data are given as mean&#x02009;&#x000b1;&#x02009;SEM; ***Significantly different from the scrambled oligo control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 (unpaired <italic>t</italic>-test). <bold>(D)</bold>. The G<sub>i/o</sub> inhibitor PTX but not the protein kinase C inhibitor BIM I inhibited NK1-induced LVA Ca<sup>2+</sup> current inhibition. Example time courses of the effects of 1&#x02009;&#x003bc;<italic>M</italic> S9SP and 1&#x02009;&#x003bc;<italic>M</italic> Z944 on the LVA currents recorded from small-diameter DRG neurons after the PTX (400&#x02009;ng/ml; overnight; <bold>D<sub>1</sub>)</bold> or BIM I (200&#x02009;n<italic>M</italic>; 20 min; <bold>D<sub>2</sub></bold>) pretreatment. Plotted are peak LVA current amplitudes; periods of drug application are indicated by the <italic>vertical gray bars</italic>; VGCC inhibitor MIB (3&#x02009;&#x003bc;<italic>M</italic>) was used instead of Z944 in <bold>(D<sub>1</sub>)</bold>. <bold>(E)</bold> Scatter plot summarizing the experiments exemplified in <bold>(D<sub>1</sub>, D<sub>2</sub>)</bold>, similar to that shown in <bold>(B)</bold>. ***Significantly different from the control, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 (unpaired <italic>t</italic>-test). The data for the S9SP inhibition in control conditions (<italic>black circles</italic>) are the same as in <xref ref-type="fig" rid="f1">Figure 1B</xref> and are included for comparison. BIM I, bisindolylmaleimide I; MIB, mibefradil; PTX, pertussis toxin; siRNA, small interfering RNA; VGCC, voltage-gated Ca<sup>2+</sup> channel.</p></caption><graphic xlink:href="fig-2"/></fig><p>In accord with these findings, overnight pre-treatment of DRG cultures with the G<sub>i/o</sub> inhibitor, pertussis toxin (PTX; 400&#x02009;ng/ml) completely abolished the S9SP-mediated T-type current inhibition (<xref ref-type="fig" rid="f2">Fig. 2D<sub>1</sub>, E</xref>). A protein kinase C inhibitor, bisindolylmaleimide I (BIM I, 200&#x02009;n<italic>M</italic>) was without a significant effect (<xref ref-type="fig" rid="f2">Fig. 2D<sub>2</sub>, E</xref>). These data indicate that, similar to their effect on the M channels, NK1 receptors use the G<sub>i/o</sub>-mediated pathway to inhibit T-type channels in DRG neurons. Immunohistochemical localization of Ca<sub>V</sub>3.2, NK1, and a major M channel subunit, KCNQ2 revealed that, indeed, Ca<sub>V</sub>3.2 co-localizes with NK1 and KCNQ2 in many DRG neurons, particularly in those of a small diameter (<xref ref-type="supplementary-material" rid="SD2">Supplementary Fig. S2</xref>).</p><p>Washout of S9SP (up to 5&#x02009;min) did not restore LVA current amplitude (not shown) but the inhibition was completely reversed by the reducing agent dithiothreitol (DTT; 1&#x02009;m<italic>M</italic>), even in the continued presence of S9SP (<xref ref-type="fig" rid="f3">Fig. 3A</xref>); DTT on its own did not significantly affect LVA current amplitude, but it rendered S9SP ineffective when both compounds were applied together (<xref ref-type="fig" rid="f3">Fig. 3B</xref>).</p><fig id="f3" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 3.</bold></label><caption><p><bold>SP inhibits T-type calcium channels using a redox-dependent mechanism. (A)</bold> S9SP-induced inhibition of LVA current in DRG neurons is reversed by the reducing agent DTT. <bold>(A<sub>1</sub>)</bold> Example time course of the effects of 1&#x02009;&#x003bc;<italic>M</italic> S9SP, 1&#x02009;m<italic>M</italic> DTT, and 3&#x02009;&#x003bc;<italic>M</italic> MIB on the LVA Ca<sup>2+</sup> current recorded from small-diameter DRG neurons. <italic>Inset</italic> shows example current traces; the current protocol was similar to that shown in <xref ref-type="fig" rid="f1">Figure 1A<sub>1</sub></xref>. <bold>(A<sub>2</sub>)</bold> Summarizes the effects. <bold>(B, B<sub>1</sub>, B<sub>2</sub>)</bold> DTT prevents the SP-induced LVA current inhibition. Experiments are similar to those shown in <bold>(A),</bold> but DTT is applied both before and during the S9SP application; layout and labeling are similar to <bold>(A)</bold>. <bold>(C)</bold> Example time course of the effect of H<sub>2</sub>O<sub>2</sub> (300&#x02009;&#x003bc;<italic>M</italic>) on LVA Ca<sup>2+</sup> currents in small-diameter DRG neurons. Note that DTT (1&#x02009;m<italic>M</italic>) could almost completely reverse the inhibition. <bold>(C<sub>2</sub>)</bold> Summarizes the data for experiments shown in <bold>(C<sub>1</sub>)</bold>. <bold>(D<sub>1</sub>, D<sub>2</sub>)</bold> Pre-application of H<sub>2</sub>O<sub>2</sub> precludes the effect of S9SP on LVA Ca<sup>2+</sup> currents in small-diameter DRG neurons. Layout and labeling are similar to <bold>(A&#x02013;C)</bold>. <bold>(E)</bold> Summarized data of the effect of the mitochondrial electron transport chain inhibitor, Ant.A (1&#x02009;&#x003bc;<italic>M</italic>) on the LVA currents in DRG neurons. <bold>(E<sub>1</sub>)</bold> Ant.A inhibited LVA current, an effect that was completely reversed by DTT (1&#x02009;m<italic>M</italic>). <bold>(E<sub>2</sub>)</bold> S9SP applied after the Ant.A produced only marginal further inhibition of LVA current. The number of experiments is shown within the bars. <italic>Asterisks</italic> indicate significant difference from the group indicated by the <italic>line connector</italic> with *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, or ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 (paired <italic>t</italic>-test). In all bar charts, data are shown as mean&#x02009;&#x000b1;&#x02009;SEM. Ant.A, antimycin A; DTT, dithiothreitol; SP, substance P.</p></caption><graphic xlink:href="fig-3"/></fig><p>S9SP had a similar effect on recombinant Ca<sub>V</sub>3.2 (main T-type channel subunit in DRG) that was transiently overexpressed in human embryonic kidney (HEK293) cells together with NK1 receptors (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1A</xref>). The inhibition of T-type channels by S9SP was accompanied by a modest leftward shift of the Ca<sub>V</sub>3.2 voltage dependence (<xref ref-type="supplementary-material" rid="SD3">Supplementary Fig. S3A<sub>1</sub></xref>) and a small but significant slowing of the inactivation kinetics (<xref ref-type="supplementary-material" rid="SD3">Supplementary Fig. S3A<sub>2</sub></xref>). In accord with previous findings (<xref rid="B58" ref-type="bibr">58</xref>), in DRG neurons, S9SP had no significant effect on the high-voltage-activated (HVA) Ca<sup>2+</sup> currents that are mainly conducted by N-, P/Q-, and L-type VGCCs (<xref rid="B55" ref-type="bibr">55</xref>) (<xref ref-type="supplementary-material" rid="SD3">Supplementary Fig. S3B</xref>).</p><p>Reversibility of the S9SP-induced T-type current inhibition by DTT suggested a redox-related mechanism. Thus, we investigated whether exogenous or endogenous ROS can produce action similar to S9SP on the channels. Bath application of H<sub>2</sub>O<sub>2</sub> (300&#x02009;&#x003bc;<italic>M</italic>) inhibited LVA current in cultured DRG neurons by &#x0223c;20% (<xref ref-type="fig" rid="f3">Fig. 3C, D</xref>; scatter plots for inhibition in each individual neuron in this and other similar experiment series are shown in <xref ref-type="supplementary-material" rid="SD4">Supplementary Fig. S4</xref>). The effect of H<sub>2</sub>O<sub>2</sub> was also reversed by DTT. Application of S9SP after (and in the presence of) H<sub>2</sub>O<sub>2</sub> did not produce a significant further inhibition of the LVA current (<xref ref-type="fig" rid="f3">Fig. 3D</xref>). H<sub>2</sub>O<sub>2</sub> also inhibited recombinant Ca<sub>V</sub>3.2, an effect that was reversed by DTT (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1B</xref>).</p><p>The mitochondrial electron transport chain (ETC) is one of the main sources of intracellular ROS (<xref rid="B70" ref-type="bibr">70</xref>), and SP was shown to induce ROS release from mitochondria in DRG neurons (<xref rid="B33" ref-type="bibr">33</xref>). Inhibition of the ETC complex III with antimycin A has been shown to cause a burst release of mitochondrial ROS (<xref rid="B76" ref-type="bibr">76</xref>), and antimycin A-induced ROS release augmented the activity of redox-sensitive M-type K<sup>+</sup> channels in DRG neurons (<xref rid="B33" ref-type="bibr">33</xref>). Consistently, application of antimycin A (1&#x02009;&#x003bc;<italic>M</italic>) inhibited LVA current in DRG by &#x0223c;25% (<xref ref-type="fig" rid="f3">Fig. 3E</xref>), and this effect was completely reversed by DTT (<xref ref-type="fig" rid="f3">Fig. 3E<sub>1</sub></xref>). S9SP applied after the pre-application and in the continuous presence of antimycin A only had a marginal further effect (<xref ref-type="fig" rid="f3">Fig. 3E<sub>2</sub></xref>).</p><p>These experiments suggest that a major component of S9SP-mediated T-type channel inhibition is mediated by endogenous ROS (although a contribution from additional mechanisms cannot be excluded).</p></sec><sec id="s004"><title>SP acts by increasing Ca<sub>V</sub>3.2 sensitivity to ambient zinc</title><p>Recently, we showed that hydrogen sulfide (H<sub>2</sub>S) inhibits Ca<sub>V</sub>3.2 by increasing channel sensitivity to zinc (<xref rid="B15" ref-type="bibr">15</xref>), a trace metal that inhibits Ca<sub>V</sub>3.2 at sub-micromolar concentrations and is present in sufficient amounts in biological fluids to affect Ca<sub>V</sub>3.2 activity (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B66" ref-type="bibr">66</xref>). Therefore, we tested whether a similar mechanism might account for the SP-mediated T-type channel inhibition.</p><p>Application of 750&#x02009;n<italic>M</italic> ZnCl<sub>2</sub> caused inhibition of LVA current in DRG neurons by &#x0223c;25% (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; <italic>n</italic>&#x02009;=&#x02009;9; <xref ref-type="fig" rid="f3">Fig. 3A</xref>), but when S9SP was applied in the presence of zinc, it had no further inhibitory effect (<xref ref-type="fig" rid="f4">Fig. 4A</xref>). Furthermore, S9SP did not produce any effect in the presence of the zinc chelator N,N,N&#x02032;,N&#x02032;<italic>-</italic>Tetrakis(2-pyridylmethyl)ethylenediamine (TPEN; 10&#x02009;&#x003bc;<italic>M</italic>; <xref ref-type="fig" rid="f4">Fig. 4B</xref> and <xref ref-type="supplementary-material" rid="SD4">Supplementary Fig. S4</xref>). S9SP-induced inhibition was completely reversed by bath application of TPEN (still in the presence of S9SP, <xref ref-type="fig" rid="f4">Fig. 4C</xref> and <xref ref-type="supplementary-material" rid="SD4">Supplementary Fig. S4</xref>). Similar to DRG neurons, SP- and H<sub>2</sub>O<sub>2</sub>-induced inhibitions of recombinant Ca<sub>V</sub>3.2 were prevented by TPEN (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1C, D</xref>).</p><fig id="f4" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 4.</bold></label><caption><p><bold>Extracellular zinc mimics SP action on T-type Ca<sup>2+</sup> channels. (A)</bold> Extracellular ZnCl<sub>2</sub> inhibited LVA Ca<sup>2+</sup> currents in DRG neurons. <bold>(A<sub>1</sub>)</bold> Example time course of the effect of ZnCl<sub>2</sub> (750&#x02009;n<italic>M</italic>), S9SP (1&#x02009;&#x003bc;<italic>M</italic>), and MIB (3&#x02009;&#x003bc;<italic>M</italic>) on the LVA Ca<sup>2+</sup> current recorded form small-diameter DRG neurons using whole-cell patch clamp. Periods of drug application are indicated by the <italic>vertical gray bars</italic>; <bold>(A<sub>2</sub>)</bold> summarizes the effects. <bold>(B)</bold> Zinc chelator TPEN (10&#x02009;&#x003bc;<italic>M</italic>) prevents SP-mediated LVA current inhibition in DRG neurons. <bold>(B<sub>1</sub>)</bold> Example time course of the effect of TPEN (10&#x02009;&#x003bc;<italic>M</italic>), S9SP (1&#x02009;&#x003bc;<italic>M</italic>), and MIB (3&#x02009;&#x003bc;<italic>M</italic>) on the LVA current; <bold>(B<sub>2</sub>)</bold> summarizes the effects; layout and labeling are similar to <bold>(A)</bold>. <bold>(C)</bold> TPEN reverses the SP-induced LVA current inhibition in DRG neurons. <bold>(C<sub>1</sub>)</bold> Example time course of the effect of S9SP (1&#x02009;&#x003bc;<italic>M</italic>), TPEN (10&#x02009;&#x003bc;<italic>M</italic>), and MIB (3&#x02009;&#x003bc;<italic>M</italic>) on the LVA current; <bold>(C<sub>2</sub>)</bold> summarizes the effects; layout and labeling are similar to <bold>(A, B)</bold>. <italic>Asterisks</italic> indicate significant difference from the group indicated by the <italic>line connector</italic> with **<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01 or ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 (paired <italic>t</italic>-test). In all bar charts, data are shown as mean&#x02009;&#x000b1;&#x02009;SEM. TPEN, N,N,N&#x02032;,N&#x02032;<italic>-</italic>Tetrakis(2-pyridylmethyl)ethylenediamine.</p></caption><graphic xlink:href="fig-4"/></fig><p>To accept a hypothesis that SP promotes T-type channel inhibition by ambient zinc and that this effect is mediated by a redox-dependent mechanism, two questions need to be addressed. (i) Is there enough ambient zinc to mediate the observed effects (as all our solutions are nominally zinc free, unless stated otherwise)? (ii) Does SP induce any changes to extracellular or intracellular zinc levels in DRG neurons?</p><p>First, we measured the zinc content of extracellular solutions and media using the atomic absorption spectroscopy (AAS; <xref ref-type="fig" rid="f5">Fig. 5A</xref>). Both the DRG culture medium and the extracellular bath solution contained micromolar concentrations of zinc (&#x0223c;10&#x02009;&#x003bc;<italic>M</italic> in Dulbecco's modified Eagle medium [DMEM] and &#x0223c;5&#x02009;&#x003bc;<italic>M</italic> in extracellular bath solution), which were similar to the reported plasma zinc levels in humans (<xref rid="B44" ref-type="bibr">44</xref>). There were no detectable changes in zinc content in the extracellular media after up to 10&#x02009;min incubation of DRG cultures with S9SP (<xref ref-type="fig" rid="f5">Fig. 5A</xref>). Notably, AAS detects total zinc content and the free zinc is likely to be significantly lower than the 5&#x02013;10&#x02009;&#x003bc;<italic>M</italic>; this can explain the significant inhibition of LVA current observed in the extracellular solution supplemented with 750&#x02009;n<italic>M</italic> ZnCl<sub>2</sub> (<xref ref-type="fig" rid="f4">Fig. 4A</xref>).</p><fig id="f5" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 5.</bold></label><caption><p><bold>SP does not change extracellular or intracellular zinc levels in DRG cultures. (A)</bold> Nominally zinc-free media contains micromolar levels of zinc. Atomic absorption spectroscopy measurements of total zinc in experimental media (as indicated); <italic>left</italic> eight bars correspond to the standard solutions of ZnCl<sub>2</sub> in de-ionized water. Bars in the <italic>middle</italic> correspond to the levels of zinc in experimental media: DMEM is a DRG culture medium tested either on its own or collected from a DRG culture plate (&#x0201c;DMEM&#x0201d; and &#x0201c;DMEM+DRG&#x0201d;); EC is an extracellular solution used in patch-clamp and imaging experiments tested either on its own or collected from a DRG culture plate (&#x0201c;EC&#x0201d; and &#x0201c;EC+DRG&#x0201d;). Two bars on the <italic>right</italic> correspond to the experiments where zinc content has been analyzed in the EC of DRG cultures treated with 1&#x02009;&#x003bc;<italic>M</italic> S9SP for 2 or 10&#x02009;min (as indicated). <bold>(B)</bold> SP does not produce detectable rises in intracellular zinc levels in DRG neurons. Fluorescence imaging of cultured small-diameter DRG neurons loaded with zinc fluorophore, FluoZin<sup>&#x02122;</sup>-3AM. Example time course of the effect of S9SP (1&#x02009;&#x003bc;<italic>M</italic>), ZnCl<sub>2</sub> (1.5&#x02009;m<italic>M</italic>) and zinc ionophore, ZnPy (10&#x02009;&#x003bc;<italic>M</italic>) on FluoZin-3 fluorescence. Corresponding images of the culture under basal conditions and after the application of ZnPy (as indicated) are shown on the <italic>right</italic>. <bold>(C)</bold> Increase in FluoZin-3 fluorescence induced by 10&#x02009;&#x003bc;<italic>M</italic> ZnPy is completely reversed by 20&#x02009;&#x003bc;<italic>M</italic> zinc chelator, TPEN but is unaffected by 1&#x02009;m<italic>M</italic> DTT. <bold>(D, E)</bold> Summarize the experiments presented in <bold>(B, C),</bold> respectively. <bold>(D)</bold>
<italic>Asterisks</italic> indicate significant difference from the basal fluorescence with ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 (paired <italic>t</italic>-test); <bold>(E)</bold>
<italic>Asterisks</italic> indicate significant difference from the fluorescence in the presence of ZnPy with ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 (paired <italic>t</italic>-test). In all bar charts, data are shown as mean&#x02009;&#x000b1;&#x02009;SEM. DMEM, Dulbecco's modified Eagle medium; ZnPy, zinc pyrithione. To see this illustration in color, the reader is referred to the web version of this article at <uri xlink:type="simple" xlink:href="http://www.liebertonline.com/ars">www.liebertonline.com/ars</uri></p></caption><graphic xlink:href="fig-5"/></fig><p>Next, we measured intracellular zinc levels using confocal fluorescence microscopy of DRG cultures loaded with the zinc indicator FluoZin<sup>&#x02122;</sup>-3AM. Application of S9SP did not produce detectable changes in intracellular zinc levels; however, large responses were recorded in response to 1.5&#x02009;m<italic>M</italic> ZnCl<sub>2</sub> or zinc ionophore zinc pyrithione (ZnPy; 10&#x02009;&#x003bc;<italic>M</italic>; <xref ref-type="fig" rid="f5">Fig. 5B, D</xref>). In a separate experiment, we detected significant intracellular zinc transients in response to acidification (pH 5.5; <xref ref-type="supplementary-material" rid="SD5">Supplementary Fig. S5</xref>). Acidification has been previously shown to release intracellular zinc from cytosolic zinc-cysteine complexes (<xref rid="B28" ref-type="bibr">28</xref>) and, thus, acidification-induced zinc transients are likely to represent intracellular zinc release.</p><p>We then tested whether DTT can chelate zinc, as has been suggested (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B48" ref-type="bibr">48</xref>). We first loaded DRG cultures with zinc by the application of ZnPy and then applied, in sequence, 1&#x02009;m<italic>M</italic> DTT and 20&#x02009;&#x003bc;<italic>M</italic> TPEN (still in the presence of ZnPy; <xref ref-type="fig" rid="f5">Fig. 5C, E</xref>). Cell-permeable (<xref rid="B19" ref-type="bibr">19</xref>) DTT did not alter the elevated zinc levels, whereas TPEN completely reversed the increase in fluorescence produced by ZnPy (<xref ref-type="fig" rid="f5">Fig. 5C, E</xref>). This suggests that TPEN effectively competed for zinc binding with the zinc-sensitive dye at a molar ratio of 2:1, whereas DTT was unable to produce such an effect even at a molar ratio of 200:1. The experiments presented in <xref ref-type="fig" rid="f5">Figure 5</xref> and <xref ref-type="supplementary-material" rid="SD5">Supplementary Figure S5</xref> established that (i) ambient zinc is present in nominally zinc-free solutions and media at levels that are sufficient to affect Ca<sub>V</sub>3.2 activity (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B66" ref-type="bibr">66</xref>); (ii) we could not detect significant changes in intracellular or extracellular zinc levels in DRG neurons in response to SP; and (iii) we could not detect zinc chelator activity of DTT. Although this last observation cannot rule out zinc binding by DTT, in principle, it argues against zinc chelation by DTT as the reason underlying the reversibility of the SP effect on T-type channels by DTT in our experiments. Instead, we hypothesize that oxidation increases and reduction decreases channel sensitivity to zinc. We further suggest that SP induces T-type channel inhibition in DRG neurons by producing ROS-mediated modification of T-type channel protein, which, in turn, alters the channel sensitivity to zinc.</p><p>To directly test whether SP treatment changes zinc sensitivity of Ca<sub>V</sub>3.2, we investigated concentration dependency of zinc effect on the recombinant Ca<sub>V</sub>3.2 overexpressed in HEK293 cells together with NK1 receptors with and without S9SP treatment. We applied 10&#x02009;&#x003bc;<italic>M</italic> TPEN in the nominally zinc-free bath solution at the beginning of each of such experiments to achieve near-zero extracellular free zinc levels and then applied increasing concentrations of ZnCl<sub>2</sub> (now without TPEN; <xref ref-type="fig" rid="f6">Fig. 6A, B</xref>).</p><fig id="f6" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 6.</bold></label><caption><p><bold>SP increases zinc-mediated inhibition of Ca<sub>V</sub>3.2 that is mediated by a high-affinity binding site. (A)</bold> Exemplary patch-clamp recording from HEK293 cell co-transfected with Ca<sub>V</sub>3.2 and NK1 showing concentration dependency of the effect of extracellular ZnCl<sub>2</sub> on Ca<sub>V</sub>3.2 currents. TPEN (10&#x02009;&#x003bc;M) was applied at the beginning of the experiment to record Ca<sub>V</sub>3.2 current amplitude at a near-zero extracellular zinc concentration. Increasing concentrations of ZnCl<sub>2</sub> were applied during the periods indicated by <italic>vertical gray bars</italic>. <bold>(B)</bold> Experiment similar to <bold>(A)</bold> but increasing ZnCl<sub>2</sub> concentrations were applied after application of 1&#x02009;&#x003bc;<italic>M</italic> S9SP; 1&#x02009;&#x003bc;<italic>M</italic> S9SP was present in all ZnCl<sub>2</sub> solutions. <bold>(C)</bold>. The data from 6&#x02013;12 experiments as in <bold>(A, B)</bold> were fit to two-component logistic function (see <xref ref-type="sec" rid="s008">Materials and Methods</xref> section). The solution containing 10&#x02009;&#x003bc;<italic>M</italic> TPEN and no added ZnCl<sub>2</sub> was assigned a free zinc concentration of 0.05&#x02009;n<italic>M</italic>. In control conditions, the IC<sub>50(1)</sub> was 0.25&#x02009;&#x000b1;&#x02009;1.4&#x02009;n<italic>M</italic> and the IC<sub>50(2)</sub> was 495&#x02009;&#x000b1;&#x02009;326&#x02009;n<italic>M</italic>. After the S9SP treatment, the IC<sub>50(1)</sub> was 0.35&#x02009;&#x000b1;&#x02009;0.25&#x02009;n<italic>M</italic> and the IC<sub>50(2)</sub> was 923&#x02009;&#x000b1;&#x02009;582&#x02009;n<italic>M</italic>. <bold>(C)</bold> Data are shown as mean&#x02009;&#x000b1;&#x02009;SEM. HEK, human embryonic kidney.</p></caption><graphic xlink:href="fig-6"/></fig><p>The concentration dependency was best fit with the two-component logistic function (<xref ref-type="fig" rid="f6">Fig. 6C</xref>; see <xref ref-type="sec" rid="s008">Materials and Methods</xref> section). The data obtained in control conditions could be fit well with the one-component function as well [in agreement with previous reports (<xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B66" ref-type="bibr">66</xref>); not shown], as the inhibition at low nanomolar zinc concentrations was small. However, a far better fit was achieved with the two-component logistic function, which clearly separated two zinc effects (<xref ref-type="fig" rid="f6">Fig. 6C</xref>). Such bi-phasic concentration dependence is likely to indicate that Ca<sub>V</sub>3.2 uniquely possesses high-affinity (sub-micromolar) and low-affinity (micromolar) zinc binding sites. The latter is likely to be shared with other Ca<sub>V</sub>3 subunits and other types of VGCC channels, as these are also inhibited by micromolar (but not nanomolar) zinc levels (<xref rid="B6" ref-type="bibr">6</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B66" ref-type="bibr">66</xref>).</p><p>S9SP treatment strongly increased the efficacy of zinc-mediated inhibition <italic>via</italic> the high-affinity mechanism while having no effect on the inhibition at higher concentrations (<xref ref-type="fig" rid="f6">Fig. 6C</xref>). The maximal inhibition at the high-affinity site in the control and S9SP-treated cells was 9.9%&#x02009;&#x000b1;&#x02009;11.3% and 44.1%&#x02009;&#x000b1;&#x02009;5.1%, respectively; the IC<sub>50</sub> values for high- and low-affinity sites did not change significantly. We estimated that free zinc concentrations in our solutions are in the low nanomolar range, since S9SP inhibited Ca<sub>V</sub>3.2 in nominally zinc-free solutions by &#x0223c;40% (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1A</xref> and <xref ref-type="fig" rid="f6">Fig. 6</xref>); however, TPEN produced only marginal augmentation of Ca<sub>V</sub>3.2 currents in control conditions (<xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1C</xref>, D and <xref ref-type="fig" rid="f6">Fig. 6A, B</xref>). These experiments also explain why application of 750&#x02009;n<italic>M</italic> extracellular zinc abolished the S9SP effect (<xref ref-type="fig" rid="f4">Fig. 4A</xref>), as at concentrations higher than 100&#x02009;n<italic>M</italic> the difference in zinc-induced inhibition between control and S9SP-treated cells started to disappear (<xref ref-type="fig" rid="f6">Fig. 6C</xref>). The presence of low-nanomolar free zinc in nominally zinc-free solutions introduces a slight systematic error to the concentration-dependency measurements; however, we believe that the overall conclusion that SP treatment enhances inhibition of Ca<sub>V</sub>3.2 by zinc acting at its high-affinity site is valid.</p><p>The unique high-affinity metal-binding site of Ca<sub>V</sub>3.2 has been elucidated (<xref rid="B27" ref-type="bibr">27</xref>): It is composed of an Asp-Gly-His motif in the extracellular S3&#x02013;S4 linker of the domain I and a separate Asp in the S1&#x02013;S2 linker of the same domain (<xref ref-type="fig" rid="f7">Fig. 7A<sub>1,</sub> A<sub>2</sub></xref>); this site is also critical for channel modulation by redox agents (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>, <xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B48" ref-type="bibr">48</xref>). His191 plays a central role in the zinc-mediated channel inhibition. This residue is absent in Ca<sub>V</sub>3.1 and Ca<sub>V</sub>3.3; accordingly, these channels are far less sensitive to zinc.</p><fig id="f7" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 7.</bold></label><caption><p><bold>High-affinity zinc binding site is necessary for Ca<sub>V</sub>3 channel sensitivity to SP. (A<sub>1</sub>)</bold> Depicts the amino-acid sequence alignment of the transmembrane segments S3 and S4 of domain I (with extracellular linker) of Ca<sub>V</sub>3.1 and Ca<sub>V</sub>3.2; non-conserved H191 of Ca<sub>V</sub>3.2 is highlighted in <italic>red</italic>. <bold>(A<sub>2</sub>)</bold> Simplified schematic of domain I of Ca<sub>V</sub>3 channels. <bold>(B)</bold> H191Q substitution in Ca<sub>V</sub>3.2 renders the channel insensitive to SP inhibition. <bold>(B<sub>1</sub>)</bold> Example time course of the effect of S9SP (1&#x02009;&#x003bc;<italic>M</italic>), DTT (1&#x02009;m<italic>M</italic>), and MIB (3&#x02009;&#x003bc;<italic>M</italic>) on the Ca<sub>V</sub>3.2(H191Q) mutant recorded in HEK293 cell co-transfected with NK1 receptor; <italic>inset</italic> shows example current traces. <bold>(B<sub>2</sub>)</bold> Shows summary of the effects. <bold>(C)</bold> Q172H substitution in Ca<sub>V</sub>3.1 renders the channel sensitive to SP inhibition. <bold>(C<sub>1</sub>, C<sub>2</sub>)</bold> Example time courses of the effects of S9SP (1&#x02009;&#x003bc;<italic>M</italic>) and MIB (3&#x02009;&#x003bc;<italic>M</italic>) on the wtCa<sub>V</sub>3.1 <bold>(C<sub>1</sub>)</bold> and Ca<sub>V</sub>3.1(Q172H) mutant <bold>(C<sub>2</sub>)</bold> recorded in HEK293 cell co-transfected with NK1 receptor. <italic>Insets</italic> show example current traces; <bold>(C<sub>3</sub>)</bold> shows summary of the effects. The number of experiments is shown within the bars in <bold>(B<sub>2</sub>, C<sub>3</sub>)</bold>. <italic>Asterisks</italic> indicate significant difference from the group indicated by the <italic>line connector</italic> with ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001 (paired <italic>t</italic>-test). In all bar charts, data are shown as mean&#x02009;&#x000b1;&#x02009;SEM. To see this illustration in color, the reader is referred to the web version of this article at <uri xlink:type="simple" xlink:href="http://www.liebertonline.com/ars">www.liebertonline.com/ars</uri></p></caption><graphic xlink:href="fig-7"/></fig><p>To test whether SP-mediated Ca<sub>V</sub>3.2 channel inhibition requires this high-affinity zinc-binding site, we tested the SP sensitivity of two reciprocal mutants: Ca<sub>V</sub>3.2 with H191 substituted by glutamine (Ca<sub>V</sub>3.2H191Q) and Ca<sub>V</sub>3.1 with H-to-Q substitution at the homologous position 172 (Ca<sub>V</sub>3.1Q172H; <xref ref-type="fig" rid="f7">Fig. 7A<sub>1</sub>, A<sub>2</sub></xref>). Notably, Ca<sub>V</sub>3.2H191Q displayed no sensitivity to SP (<xref ref-type="fig" rid="f7">Fig. 7B</xref>); current amplitude in the presence of S9SP was 103.1%&#x02009;&#x000b1;&#x02009;9.8% of basal value (<italic>n</italic>&#x02009;=&#x02009;8) <italic>versus</italic> 69.8%&#x02009;&#x000b1;&#x02009;6.8% for the wtCa<sub>V</sub>3.2 (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; <italic>n</italic>&#x02009;=&#x02009;13; <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1A</xref>). Similarly insensitive to S9SP was the wild-type Ca<sub>V</sub>3.1 (<xref ref-type="fig" rid="f7">Fig. 7C<sub>1</sub></xref>); whereas Ca<sub>V</sub>3.1Q172H mutant, in contrast, displayed small but significant inhibition by S9SP (10.4%&#x02009;&#x000b1;&#x02009;1.6%; <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05; <italic>n</italic>&#x02009;=&#x02009;8; <xref ref-type="fig" rid="f7">Fig. 7C<sub>2</sub>, C<sub>3</sub></xref>). In accord with previous reports, Q172H substitution in Ca<sub>V</sub>3.1 only partially restored channel sensitivity to sub-millimolar zinc, as the entire binding site is required for the full effect (<xref rid="B27" ref-type="bibr">27</xref>).</p></sec><sec id="s005"><title>Effects of novel T-type Ca<sup>2+</sup> channel modulators on sensory neuron excitability</title><p>The T-type Ca<sup>2+</sup> current is an important regulator of sensory neuron excitability (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B17" ref-type="bibr">17</xref>, <xref rid="B18" ref-type="bibr">18</xref>, <xref rid="B20" ref-type="bibr">20</xref>, <xref rid="B23" ref-type="bibr">23</xref>, <xref rid="B24" ref-type="bibr">24</xref>, <xref rid="B51" ref-type="bibr">51</xref>, <xref rid="B71" ref-type="bibr">71</xref>, <xref rid="B75" ref-type="bibr">75</xref>). To evaluate the contribution of T-type Ca<sup>2+</sup> channel modulation to the effects of SP on sensory neuron excitability both <italic>in vitro</italic> and <italic>in vivo</italic>, we used recently developed specific and selective T-type Ca<sup>2+</sup> channel modulators: spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one (ST101), a highly active Ca<sub>V</sub>3 potentiator (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B45" ref-type="bibr">45</xref>) with an EC<sub>50</sub> in sub-nanomolar range, and Z944, a selective Ca<sub>V</sub>3 inhibitor with IC<sub>50</sub> &#x0223c;50&#x02009;n<italic>M</italic> (<xref rid="B67" ref-type="bibr">67</xref>). Z944 (1&#x02009;&#x003bc;<italic>M</italic>) inhibited LVA current in DRG neurons by 71.4%&#x02009;&#x000b1;&#x02009;2.7% (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; <italic>n</italic>&#x02009;=&#x02009;7), without a noticeable effect on HVA current (<xref ref-type="fig" rid="f8">Fig. 8A</xref>); at this concentration, Z944 produced no significant effect on L- and N-type VGCCs, Nav1.5 and hERG channels (<xref rid="B67" ref-type="bibr">67</xref>).</p><fig id="f8" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 8.</bold></label><caption><p><bold>Modulation of T-type channel activity in DRG neurons reveals the channel's role in control over the excitability. (A)</bold> Z944 potently inhibits LVA but not HVA Ca<sup>2+</sup> currents in DRG neurons. <bold>(A<sub>1</sub>)</bold> Shows example whole-cell patch clamp recordings, and <bold>(A<sub>2</sub>)</bold> shows summarized data for the effects of 1&#x02009;&#x003bc;<italic>M</italic> Z944 on LVA (<italic>left</italic>) and HVA (<italic>right</italic>) Ca<sup>2+</sup> currents; voltage protocols are depicted above the traces. <bold>(B)</bold> ST101 potently augments LVA but not HVA Ca<sup>2+</sup> currents in DRG neurons; layout and labeling are similar to <bold>(A<sub>1</sub>, A<sub>2</sub>)</bold>; to inhibit HVA current, MIB was used at 10&#x02009;&#x003bc;<italic>M</italic>. <bold>(A, B)</bold> HVA currents were recorded from neurons lacking the LVA current. *<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, ***<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; paired <italic>t</italic>-test. <bold>(C<sub>1</sub>, C<sub>2</sub></bold><bold>)</bold> Effect of Z944 <bold>(C<sub>1</sub>)</bold> and a T-type channel activator, ST101 <bold>(C<sub>2</sub>)</bold> on small DRG neuron excitability recorded in perforated patch-clamp current mode. Current injection protocol is depicted beneath the traces in <bold>(C)</bold>. Extended analysis of the ST101 and Z944 effects on excitability is given in <xref ref-type="supplementary-material" rid="SD6">Supplementary Figure S7</xref>. <bold>(A, B)</bold> Data are shown as mean&#x02009;&#x000b1;&#x02009;SEM. HVA, high-voltage activated; ST101, spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one. To see this illustration in color, the reader is referred to the web version of this article at <uri xlink:type="simple" xlink:href="http://www.liebertonline.com/ars">www.liebertonline.com/ars</uri></p></caption><graphic xlink:href="fig-8"/></fig><p>ST101 (1&#x02009;n<italic>M</italic>) enhanced peak LVA current in DRG neurons by 50.6%&#x02009;&#x000b1;&#x02009;14.1% (<italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01; <italic>n</italic>&#x02009;=&#x02009;7), also without an effect on HVA current (<xref ref-type="fig" rid="f8">Fig. 8B</xref>); at 1&#x02009;n<italic>M</italic>, ST101 had no effect on delayed-rectifier K<sup>+</sup> current and voltage-gated Na<sup>+</sup> current in DRG neurons (<xref ref-type="supplementary-material" rid="SD7">Supplementary Fig. S6</xref>). Although several selective blockers of T-type Ca<sup>2+</sup> channels were reported (<xref rid="B10" ref-type="bibr">10</xref>, <xref rid="B17" ref-type="bibr">17</xref>), selective T-type channel potentiators were not available until recently.</p><p>We next tested the effect of Z944 and ST101 on DRG neuron excitability using the perforated current clamp technique. Z944 decreased (<xref ref-type="fig" rid="f8">Fig. 8C<sub>1</sub></xref>) and ST101 increased (<xref ref-type="fig" rid="f8">Fig. 8C<sub>2</sub></xref>) small DRG neuron excitability; these effects are further analyzed in <xref ref-type="supplementary-material" rid="SD6">Supplementary Figure S7</xref>: Z944 significantly increased the rheobase, decreased action potential (AP) firing, and hyperpolarized small-diameter DRG neurons without significantly affecting AP amplitude or duration. In contrast, ST101 significantly increased AP firing and depolarized E<sub>rest</sub>; AP amplitude or duration was not affected (<xref ref-type="supplementary-material" rid="SD6">Supplementary Fig. S7A&#x02013;C</xref>).</p><p>S9SP produced a pattern of effects similar to that of Z944 (<xref ref-type="supplementary-material" rid="SD6">Supplementary Fig. S7A&#x02013;C</xref>), although only the effect on rheobase (<xref ref-type="supplementary-material" rid="SD6">Supplementary Fig. S7A</xref>) reached significance. Of note, mean values and the statistical significance of the effects shown in <xref ref-type="supplementary-material" rid="SD6">Supplementary Figure S7</xref> are underestimated, since not all DRG neurons express all the necessary components of the signaling cascade. Thus, &#x0223c;40% of small DRG neurons in our cultures express LVA currents; &#x0223c;40% to 50% of small neurons express functional NK1 receptors [(<xref rid="B33" ref-type="bibr">33</xref>), present study]; and &#x0223c;70% of LVA-expressing neurons respond to S9SP. Therefore, in each series of experiments, there was a subpopulation of &#x0201c;unresponsive&#x0201d; neurons.</p><p>We further tested whether SP or a T-type Ca<sup>2+</sup> channel blocker would attenuate the excitatory effect of the pro-algesic peptide bradykinin (BK) (<xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B52" ref-type="bibr">52</xref>). BK (250&#x02009;n<italic>M</italic>) significantly reduced the rheobase, increased the AP number, and depolarized the E<sub>rest</sub> (<xref ref-type="supplementary-material" rid="SD6">Supplementary Fig. S7A&#x02013;C</xref>). When co-applied with BK, both S9SP and Z944 completely reversed the effects of BK on the rheobase and the AP number (<xref ref-type="supplementary-material" rid="SD6">Supplementary Fig. S7A, B</xref>). The BK-induced depolarization in the presence of either S9SP or Z944 was more variable (<xref ref-type="supplementary-material" rid="SD6">Supplementary Fig. S7C</xref>), perhaps reflecting the complexity of the depolarizing effects of BK (<xref rid="B25" ref-type="bibr">25</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B52" ref-type="bibr">52</xref>), but in both cases the effect of BK was no longer statistically significant.</p><p>To confirm that the effects of Z944 and ST101 on sensory neuron excitability are, indeed, mediated by T-type channels, we repeated some of the current clamp experiments in DRG neurons in which Ca<sub>V</sub>3.2 expression has been downregulated with siRNA against <italic>Cacna1h</italic>. The procedure (see <xref ref-type="sec" rid="s008">Materials and Methods</xref> section) reduced the <italic>Cacna1h</italic> transcript levels by &#x0223c;50% while having no effect on the housekeeping transcript (<italic>Gapdh</italic>; <xref ref-type="supplementary-material" rid="SD8">Supplementary Fig. S8A, B</xref>). In the <italic>Cacna1h</italic> knocked-down neurons, neither Z994 nor ST101 produced any significant effect on E<sub>rest</sub>, AP number, or rheobase (<xref ref-type="supplementary-material" rid="SD8">Supplementary Fig. S8C&#x02013;E</xref>); whereas in scrambled oligonucleotide-transfected neurons, both drugs were still effective (<italic>cf.</italic>
<xref ref-type="supplementary-material" rid="SD6">Supplementary Figs. S7</xref> and <xref ref-type="supplementary-material" rid="SD8">S8C&#x02013;E</xref>).</p><p>Taken together, the experiments reported in <xref ref-type="fig" rid="f8">Figure 8</xref> and <xref ref-type="supplementary-material" rid="SD6">Supplementary Figures S7</xref> and <xref ref-type="supplementary-material" rid="SD8">S8</xref> suggest that (i) T-type channels modulate excitability of many small-diameter DRG neurons; (ii) acute inhibition of T-type channels produces an anti-excitatory effect that can partially offset the excitatory action of BK; (iii) SP produces an anti-excitatory effect that is qualitatively similar to that produced by a T-type channel blocker; and (iv) effects of Z944 and ST101 on DRG neuron excitability are, indeed, mediated by T-type Ca<sup>2+</sup> channels.</p></sec><sec id="s006"><title>T-type Ca<sup>2+</sup> channel inhibition contributes to the peripheral anti-nociceptive effect of SP <italic>in vivo</italic></title><p>We next investigated the influence of T-type channels on peripheral sensory afferents <italic>in vivo</italic>. First, we tested whether T-type channel augmentation is, indeed, pro-nociceptive. An injection of ST101 (50&#x02009;&#x003bc;l; 0.001&#x02013;10&#x02009;nmol/site) into the rat hind paw induced a moderate but significant protective effect (&#x0201c;nocifensive&#x0201d; behavior, see <xref ref-type="sec" rid="s008">Materials and Methods</xref> section) that was indicative of moderate pain. The pro-algesic effect of ST101 was smaller than that induced by BK (50&#x02009;&#x003bc;l; 10&#x02009;nmol/site), but it was significantly stronger than that of saline (<xref ref-type="fig" rid="f9">Fig. 9A</xref>).</p><fig id="f9" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 9.</bold></label><caption><p><bold>T-type Ca<sup>2+</sup> channel contributes to the peripheral analgesic effect of SP. (A)</bold> Plantar hind-paw injection of ST101 (50&#x02009;&#x003bc;l; 0.001&#x02013;10&#x02009;nmol/site) and BK (50&#x02009;&#x003bc;l; 10&#x02009;nmol/site) induced nocifensive behavior in rats. Nocifensive behavior (time spent licking, flinching, and biting the paw) was quantified over the period of 30&#x02009;min. Extended analysis of the data is given in <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure S9</xref>. <bold>(B)</bold> Effects of plantar hind-paw injections of ST101 (0.001&#x02009;nmol/site), M channel opener, RTG (50&#x02009;&#x003bc;l; 0.1&#x02013;10&#x02009;nmol/site), Z944 (50&#x02009;&#x003bc;l; 0.005&#x02013;0.5&#x02009;nmol/site), or saline on the paw withdrawal latency on exposure to noxious heat (Hargreaves test). <bold>(C)</bold> Effects of plantar hind-paw injections of ST101 (50&#x02009;&#x003bc;l; 0.001&#x02009;nmol/site), Z944 (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site), S9SP (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site), or saline on the response rate on application of von Frey filaments of varying bending force to the plantar surface of the hind paw. <italic>Vertical dotted line</italic> indicates 60% withdrawal threshold of saline-injected rats. <bold>(D)</bold> Effects of plantar hind-paw injections of ST101 (50&#x02009;&#x003bc;l; 0.001&#x02009;nmol/site), Z944 (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site), S9SP (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site), or saline on the sensitivity to gentle touch in cotton-swab test. <bold>(E)</bold> Plantar hind-paw injection of S9SP (50&#x02009;&#x003bc;l; 0.5&#x02013;5&#x02009;nmol/site) failed to induce nocifensive behavior in rats (in contrast to BK). <sup>#</sup>, *, **, ***Significantly different from the control group <bold>(C)</bold> or from the group indicated by the <italic>line connector</italic> (all other panels) with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, or <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; Kruskal&#x02013;Wallis ANOVA and Mann&#x02013;Whitney test. All data are shown as mean&#x02009;&#x000b1;&#x02009;SEM. ANOVA, analysis of variance; BK, bradykinin; RTG, retigabine. To see this illustration in color, the reader is referred to the web version of this article at <uri xlink:type="simple" xlink:href="http://www.liebertonline.com/ars">www.liebertonline.com/ars</uri></p></caption><graphic xlink:href="fig-9"/></fig><p>Time courses of the nociceptive effects of BK and ST101 are shown in <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure S9</xref>. The nocifensive behavior induced by BK usually tailed out after 15&#x02009;min post-injection (<xref ref-type="supplementary-material" rid="SD9">Supplementary Fig. S9A</xref>); whereas the effects of ST101 showed a distinct pattern, with lower concentrations causing a delayed response and higher doses producing more immediate and shorter effects (<xref ref-type="supplementary-material" rid="SD9">Supplementary Fig. S9B</xref>). Such different kinetic patterns may indicate that excitations produced by BK and ST101 have distinct mechanisms.</p><p>We then evaluated the effects of Z944, ST101, and an M-type K<sup>+</sup> channel activator, retigabine (RTG), on animal sensitivity to noxious heat using the Hargreaves&#x02019; method. RTG has well-known peripheral analgesic activity (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B21" ref-type="bibr">21</xref>, <xref rid="B36" ref-type="bibr">36</xref>, <xref rid="B50" ref-type="bibr">50</xref>), and M-channel potentiation also contributes to the endogenous anti-nociceptive effect of SP (<xref rid="B33" ref-type="bibr">33</xref>). A peripheral hind-paw injection of Z944 (50&#x02009;&#x003bc;l; 0.005&#x02013;0.5&#x02009;nmol/site) significantly increased paw withdrawal latency on radiant heat exposure, suggesting decreased heat sensitivity (<xref ref-type="fig" rid="f9">Fig. 9B</xref>). RTG (50&#x02009;&#x003bc;l; 0.1&#x02013;10&#x02009;nmol/site) produced a similar effect. In contrast, ST101 significantly reduced withdrawal latency, indicating increased heat sensitivity (<xref ref-type="fig" rid="f9">Fig. 9B</xref>); time courses of these effects of Z944 and RTG are given in <xref ref-type="supplementary-material" rid="SD9">Supplementary Figure S9C</xref>.</p><p>Ca<sub>V</sub>3.2 is expressed in subpopulations of A&#x003b4; and C low-threshold mechanoreceptors (LTMRs) and plays a role in tuning sensitivity to light touch (<xref rid="B18" ref-type="bibr">18</xref>). Thus, we tested the effects of local application of Z944, ST101, and S9SP on a range of mechanical stimulations.</p><p>In von Frey test (see <xref ref-type="sec" rid="s008">Materials and Methods</xref> section), saline-injected rats had a 60% withdrawal threshold at 9.2&#x02009;&#x000b1;&#x02009;1.0&#x02009;g (<italic>n</italic>&#x02009;=&#x02009;25). Injections of Z944 (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site) and S9SP (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site) significantly impaired their ability to respond to stimulation, ranging from innocuous to noxious; Z944 was more efficacious in the noxious range (<xref ref-type="fig" rid="f9">Fig. 9C</xref>). In contrast, an injection of ST101 (50&#x02009;&#x003bc;l; 0.001&#x02009;nmol/site) greatly increased response rates (<xref ref-type="fig" rid="f9">Fig. 9C</xref>). The cotton swab assay (see <xref ref-type="sec" rid="s008">Materials and Methods</xref> section) also showed significantly reduced sensitivity to light touch after the S9SP injection (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site); Z944 (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site) produced a similar effect (<xref ref-type="fig" rid="f9">Fig. 9D</xref>). An injection of ST101, however, was ineffective in this type of test.</p><p>We then tested the contribution of T-type channel modulation to the peripheral effect of S9SP. Consistent with previous reports (<xref rid="B33" ref-type="bibr">33</xref>), a local hind-paw injection of S9SP (0.5&#x02013;5&#x02009;nmol/site) did not produce measurable nocifensive behavior; whereas BK induced a strong nocifensive response (<xref ref-type="fig" rid="f9">Fig. 9E</xref>).</p><p>We then pre-injected RTG, Z944, or S9SP into the rat hind paw 5&#x02009;min before the BK injection (together with the same pre-injection drug; <xref ref-type="fig" rid="f10">Fig. 10A, D</xref>). RTG served as a positive control, as it was shown to offset excitatory effects of BK and to reduce the BK-induced nociception (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B34" ref-type="bibr">34</xref>, <xref rid="B36" ref-type="bibr">36</xref>). Pre-injections of both RTG (50&#x02009;&#x003bc;l; 1&#x02013;10&#x02009;nmol/site) and Z944 (at 0.5&#x02009;nmol/site but not at 0.05&#x02009;nmol/site) significantly attenuated the BK-induced nociception. A pre-injection of S9SP (0.5&#x02009;nmol/site) also strongly suppressed the BK-induced nocifensive behavior (<xref ref-type="fig" rid="f10">Fig. 10A</xref>). Importantly, a mixture of RTG (1&#x02009;nmol/site) and Z944 (0.5&#x02009;nmol/site) was as efficacious as S9SP in reducing BK-induced nocifensive behavior and showed a tendency to be more efficacious than RTG or Z944 injected alone (<italic>p</italic>&#x02009;=&#x02009;0.059 <italic>vs.</italic> RTG alone; <xref ref-type="fig" rid="f10">Fig. 10A</xref>); this finding is consistent with a hypothesis that M-channel augmentation and T-type channel inhibition can be cumulative components of peripheral anti-nociceptive effects of SP.</p><fig id="f10" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 10.</bold></label><caption><p><bold>NK1 receptor-mediated T-type Ca<sup>2+</sup> channel inhibition is a likely contributor to the anti-nociceptive effect of SP. (A)</bold> Plantar hind-paw injections of S9SP (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site), RTG (50&#x02009;&#x003bc;l; 1&#x02013;10&#x02009;nmol/site), Z944 (50&#x02009;&#x003bc;l; 0.05&#x02013;0.5&#x02009;nmol/site) or a combination of RTG+Z944 solutions (at concentrations indicated) were administered 5&#x02009;min before the injection of BK (10&#x02009;nmol/site) and mixed together with the pre-injection drug or drug mixture in 50&#x02009;&#x003bc;l saline [schematic of the double-injection protocol is shown in <bold>(D)</bold>]. The number of animals in each group is shown within the bars. <bold>(B)</bold> Intrathecal knock-down of Ca<sub>V</sub>3.2 in lumbar DRG reduces anti-nociceptive effect of Z994 and S9SP. Animals with intrathecal injection of saline, Ca<sub>V</sub>3.2 AS ODNs, or non-targeting &#x0201c;mismatch&#x0201d; ODNs were investigated. Hind-paw injections of S9SP (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site) or Z944 (50&#x02009;&#x003bc;l; 0.5&#x02009;nmol/site) were administered 5&#x02009;min before the injection of BK (10&#x02009;nmol/site), similar to experiments shown in <bold>(A)</bold>. <bold>(C)</bold> Quantification of knock-down efficiency; the analysis was performed on the second day after the last intrathecal injection. The Ca<sub>V</sub>3.2 transcript levels in lumbar DRGs of AS ODN- and mismatch ODN-injected animals were normalized to those of saline-injected animals in the same experimental run; one to three animals per run, three independent runs. *, **, ***Significantly different from the group indicated by the line connector with <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.05, <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.01, or <italic>p</italic>&#x02009;&#x0003c;&#x02009;0.001; Kruskal&#x02013;Wallis ANOVA and Mann&#x02013;Whitney test. All data are shown as mean&#x02009;&#x000b1;&#x02009;SEM. AS, antisense; ODNs, oligodeoxynucleotides.</p></caption><graphic xlink:href="fig-10"/></fig><p>Finally, we performed <italic>in vivo</italic> knock-down of Ca<sub>V</sub>3.2 in DRG neurons by an intrathecal injection of antisense (AS) phosphorodiester oligodeoxynucleotides (ODNs) using the protocol that had been successfully used earlier for the same purpose [(<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B41" ref-type="bibr">41</xref>); <xref ref-type="sec" rid="s008">Materials and Methods</xref> section]. In saline- and mismatch ODN-injected animals, both Z944 (0.5&#x02009;nmol/site) and S9SP (0.5&#x02009;nmol/site) still significantly attenuated nocifensive behavior produced by the hind-paw BK injection. However, in Ca<sub>V</sub>3.2 AS ODN-injected animals, the nocifensive behavior produced by both Z944 and S9SP was significantly reduced (<xref ref-type="fig" rid="f10">Fig. 10B</xref>). The levels of Ca<sub>V</sub>3.2 transcript in lumbar DRGs of Ca<sub>V</sub>3.2 AS ODN-injected animals were reduced by &#x0223c;70% as compared with the saline-injected controls and mismatch ODN-injected animals (<xref ref-type="fig" rid="f10">Fig. 10C</xref>).</p></sec></sec><sec sec-type="discussion" id="s007"><title>Discussion</title><p>Here, we described a hitherto unknown endogenous signaling pathway linking NK1 receptors with Ca<sub>V</sub>3.2 channel activity and demonstrated that this pathway is involved in the paradoxical peripheral anti-nociceptive effect of SP. T-type Ca<sup>2+</sup> channels are sensitive to redox modulation; oxidizing agents or ROS inhibit channel activity (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B65" ref-type="bibr">65</xref>), whereas reducing agents such as L-cysteine or DTT reverse such inhibition and can augment channel activity above the basal level in some cases [(<xref rid="B46" ref-type="bibr">46</xref>, <xref rid="B65" ref-type="bibr">65</xref>); <xref ref-type="fig" rid="f3">Fig. 3</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1</xref>].</p><p>SP induces ROS release in immune (<xref rid="B64" ref-type="bibr">64</xref>) and epithelial (<xref rid="B60" ref-type="bibr">60</xref>) cells and in DRG neurons (<xref rid="B33" ref-type="bibr">33</xref>). Accordingly, SP-induced inhibition of T-type Ca<sup>2+</sup> channels observed in this study displayed the following features: (i) It was fully reversed or prevented by DTT (<xref ref-type="fig" rid="f3">Fig. 3</xref>); (ii) mimicked by exogenously applied H<sub>2</sub>O<sub>2</sub> (<xref ref-type="fig" rid="f3">Fig. 3</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1</xref>); and (iii) stimulated by endogenous ROS release (<xref ref-type="fig" rid="f3">Fig. 3E</xref>).</p><p>The mechanism of the redox sensitivity of T-type Ca<sup>2+</sup> channels is not entirely understood, but it requires the extracellular His191 in Ca<sub>V</sub>3.2; the other Ca<sub>V</sub>3 isoforms do not have a corresponding histidine and are largely redox insensitive (<xref rid="B47" ref-type="bibr">47</xref>). The same H191 mediates Ca<sub>V</sub>3.2 inhibition by sub-micromolar concentrations of zinc (<xref rid="B26" ref-type="bibr">26</xref>, <xref rid="B27" ref-type="bibr">27</xref>). H191 is a general metal-binding site, and it was hypothesized that it could participate in the metal-catalyzed oxidation (MCO) reaction accelerated by transition metals (<xref rid="B47" ref-type="bibr">47</xref>, <xref rid="B61" ref-type="bibr">61</xref>).</p><p>It is also possible that an oxidative modification (possibly but not necessarily at H191) can promote zinc binding or potentiate its action on the channel, thus sensitizing it to ambient concentrations of this trace metal. The following observations are in favor of this latter mechanism. (i) SP induced a large increase in zinc-mediated inhibition at the high-affinity site in Ca<sub>V</sub>3.2 (<xref ref-type="fig" rid="f6">Fig. 6</xref>). (ii) A mutation of H191 in Ca<sub>V</sub>3.2 rendered the channels insensitive to SP (<xref ref-type="fig" rid="f7">Fig. 7</xref>). (iii) Ca<sub>V</sub>3.1 is insensitive to SP but insertion of His into the position equivalent to H191 in Ca<sub>V</sub>3.2 renders the Ca<sub>V</sub>3.1 channel sensitive to SP (<xref ref-type="fig" rid="f7">Fig. 7</xref>). (iv) The zinc chelator TPEN prevents or reverses SP-induced T-type Ca<sup>2+</sup> current inhibition (<xref ref-type="fig" rid="f4">Fig. 4</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1</xref>). (v) Extracellular zinc inhibits LVA currents in DRG neurons, an effect that is similar in amplitude to that produced by SP (<xref ref-type="fig" rid="f4">Fig. 4</xref>). (vi) Extracellular zinc occludes any further inhibitory actions of SP (<xref ref-type="fig" rid="f4">Fig. 4</xref>). (vii) We could not detect any changes in intracellular or extracellular zinc levels induced by SP (<xref ref-type="fig" rid="f5">Fig. 5</xref> and <xref ref-type="supplementary-material" rid="SD5">Supplementary Fig. S5</xref>). (viii) Nominally zinc-free media contain low-nanomolar concentrations of free zinc, which are sufficient to affect channel activity when the channel is sensitized by SP (<xref ref-type="fig" rid="f6">Fig. 6</xref>); however, these levels are too low to significantly inhibit T-type channels in their tonic state. The last observation would explain why TPEN produced only a marginal effect on T-type currents under basal conditions (<xref ref-type="fig" rid="f4">Figs. 4B</xref> and <xref ref-type="fig" rid="f6">6B</xref> and <xref ref-type="supplementary-material" rid="SD1">Supplementary Fig. S1C, D</xref>).</p><p>Despite previous suggestions (<xref rid="B30" ref-type="bibr">30</xref>, <xref rid="B48" ref-type="bibr">48</xref>), we could not detect zinc chelation by DTT under our experimental conditions (<xref ref-type="fig" rid="f5">Fig. 5</xref>). Therefore, we suggest that the reversal of the SP-mediated T-type channel inhibition by DTT is due to the reducing activity of the latter.</p><p>Interestingly, there are three extracellular cysteines (residues that can be easily modified by redox mechanisms) in the IS1-IS2 linker of Ca<sub>V</sub>3.2, a domain that contributes to the high-affinity zinc-binding site (<xref rid="B27" ref-type="bibr">27</xref>). We hypothesize that cumulative oxidation of such extracellular cysteines may result in a graded increase in channel sensitivity to zinc. In such a scenario, Ca<sub>V</sub>3.2 tonically exists in a partially &#x0201c;oxidized&#x0201d; state with intermediate zinc sensitivity, which is, however, too low for inhibition by ambient zinc. This could be why in our hands TPEN or DTT had only marginal effects on channel activity under control conditions.</p><p>The partially oxidized state can then be converted to a fully oxidized state, with the highest zinc sensitivity by SP or ROS, or to a fully reduced state, with the lowest zinc sensitivity by DTT. This could account for the augmentation of tonic Ca<sub>V</sub>3.2 currents by DTT (<xref rid="B65" ref-type="bibr">65</xref>) and TPEN (<xref rid="B15" ref-type="bibr">15</xref>) that are observed in some labs, as different experimental conditions may result in different &#x0201c;tonic&#x0201d; redox states of the channel (<italic>e.g.</italic>, DTT or TPEN would potentiate fully oxidized channels). This hypothesis requires further verification.</p><p>The levels of NK receptor expression in peripheral sensory neurons are reportedly low. Thus, one immunohistochemical study found little evidence for NK receptor immunoreactivity in rat sensory neurons (<xref rid="B5" ref-type="bibr">5</xref>); whereas recent RNAseq experiments found very low levels of NK receptor transcripts in mouse DRG (<xref rid="B39" ref-type="bibr">39</xref>, <xref rid="B68" ref-type="bibr">68</xref>), although the levels were higher in human DRG (<xref rid="B16" ref-type="bibr">16</xref>). However, in both mouse (<xref rid="B39" ref-type="bibr">39</xref>) and human (<xref rid="B16" ref-type="bibr">16</xref>) DRG, the NK receptor transcript levels were comparable (or even higher) to those of the brain or lung, tissues where prominent SP signaling is well characterized. Moreover, the DRG NK receptor levels are comparable to those of BK B<sub>2</sub> receptors (<xref rid="B16" ref-type="bibr">16</xref>, <xref rid="B39" ref-type="bibr">39</xref>), which exert robust effects in DRG neurons [reviewed in Petho and Reeh (<xref rid="B52" ref-type="bibr">52</xref>)].</p><p>Perhaps low transcript levels and expression in only specific cell populations are sufficient for functional activity of such G-protein-coupled receptors. In support of this notion, <italic>in vitro</italic> and, particularly, <italic>in vivo</italic> evidence presented here and elsewhere (<xref rid="B32" ref-type="bibr">32</xref>, <xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B73" ref-type="bibr">73</xref>) clearly demonstrate the presence of functional SP signaling in DRG. In addition, NK1 receptor immunoreactivity was found throughout DRG neuron somata and often co-localized with that of Ca<sub>V</sub>3.2, especially in small-diameter neurons (<xref ref-type="supplementary-material" rid="SD2">Supplementary Fig. S2</xref>).</p><p>There is also some discrepancy regarding cellular effects of SP in cultured DRG neurons. Thus, some potentially excitatory effects, including depolarization (<xref rid="B1" ref-type="bibr">1</xref>, <xref rid="B74" ref-type="bibr">74</xref>), potentiation of Nav1.8 Na<sup>+</sup> channels (<xref rid="B7" ref-type="bibr">7</xref>), L- and N-type Ca<sup>2+</sup> channels (<xref rid="B58" ref-type="bibr">58</xref>), and sensitization of TRPV1 (<xref rid="B33" ref-type="bibr">33</xref>, <xref rid="B57" ref-type="bibr">57</xref>, <xref rid="B73" ref-type="bibr">73</xref>), were reported. However, there is no acute pain produced by local SP injections [(<xref rid="B33" ref-type="bibr">33</xref>); present study]. Application of SP to human skin by dermal microdialysis produces no painful sensation or primary afferent excitation (<xref rid="B72" ref-type="bibr">72</xref>). Thus, at present, the excitatory effects of SP in cultured neurons are difficult to reconcile with the lack of behavioral responses to local applications of SP. However, excitatory actions of SP may underlie responses of neurons innervating some internal organs, for example, bladder (<xref rid="B74" ref-type="bibr">74</xref>).</p><p>Opposing modulation of T-type channel activity by the latest generation of selective T-type channel modulators, ST101 (potentiator) and Z944 (inhibitor) confirmed the role of this channel in the control of sensory neuron excitability (<xref ref-type="fig" rid="f8">Fig. 8</xref> and <xref ref-type="supplementary-material" rid="SD6">Supplementary Figs. S7</xref> and <xref ref-type="supplementary-material" rid="SD8">S8</xref>). Accordingly, a peripheral injection of ST101 induced moderate &#x0201c;spontaneous&#x0201d; nociception and increased sensitivity to both light and noxious touch, whereas Z944 reduced heat and touch sensitivity (<xref ref-type="fig" rid="f9">Fig. 9</xref>); these effects are consistent with the analgesic efficacy of Z944 (<xref rid="B31" ref-type="bibr">31</xref>).</p><p>Importantly, we now show that both S9SP and Z944 significantly attenuate nociception induced by a peripheral injection of BK and <italic>in vivo</italic> knock-down of Ca<sub>V</sub>3.2 in DRG reduces such attenuation (<xref ref-type="fig" rid="f10">Fig. 10</xref>). Co-application of Z944 with M-channel opener RTG produced a similar anti-nociceptive effect as that of S9SP (<xref ref-type="fig" rid="f10">Fig. 10</xref>).</p><p>Since both M-type (<xref rid="B33" ref-type="bibr">33</xref>) and T-type (present study) channels are modulated by SP (although in opposite directions) <italic>via</italic> a signaling cascade that shares common initial steps, we suggest that both M-channel augmentation and T-type channel inhibition contribute to the redox-mediated anti-nociceptive action of SP in peripheral nerves (<xref ref-type="fig" rid="f11">Fig. 11</xref>). We hypothesize that since peptidergic nociceptive fibers release SP locally in response to noxious stimulation, this neuropeptide may exert local endogenous analgesia in an autocrine/paracrine fashion by simultaneous inhibition of T-type Ca<sup>2+</sup> channels and augmentation of M channels in nociceptors.</p><fig id="f11" fig-type="figure" orientation="portrait" position="float"><label><bold>FIG. 11.</bold></label><caption><p><bold>Schematic of the proposed peripheral anti-nociceptive signaling</bold>
<bold><italic>via</italic></bold>
<bold>NK1 receptors.</bold> Local tissue damage excites peptidergic nociceptors that release SP into the tissue damage area. Acting at the NK1 receptors expressed in the neighboring fiber endings (potentially including the SP-releasing fibers as well), SP triggers mitochondrial ROS release and redox-dependent inhibition of T-type Ca<sup>2+</sup> channels and potentiation of M-type K<sup>+</sup> channels, resulting in hyperpolarization and reduced excitability of the fibers. ROS, reactive oxygen species. To see this illustration in color, the reader is referred to the web version of this article at <uri xlink:type="simple" xlink:href="http://www.liebertonline.com/ars">www.liebertonline.com/ars</uri></p></caption><graphic xlink:href="fig-11"/></fig><p>Although we have previously shown that SP does induce mitochondrial ROS release in DRG neurons (<xref rid="B33" ref-type="bibr">33</xref>), the release of ROS from other, non-neuronal NK1-expressing cells surrounding the site of tissue damage cannot be excluded (particularly in the <italic>in vivo</italic> experiments), especially given the fact that the redox-sensitive site in T-type channels (but not M-type channels) is located extracellularly. Additionally, activation of NK receptors in DRG may result in the release of other substances that can modulate T-type channel activity, such as thioredoxin (<xref rid="B4" ref-type="bibr">4</xref>) or H<sub>2</sub>S (<xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>). Interestingly, both factors inhibit Ca<sub>V</sub>3.2 channels by interfering with their extracellular zinc-binding site (<xref rid="B4" ref-type="bibr">4</xref>, <xref rid="B14" ref-type="bibr">14</xref>, <xref rid="B15" ref-type="bibr">15</xref>).</p><p>Finally, although we could not detect any changes in intracellular or extracellular zinc levels in response to SP <italic>in vitro</italic>, one cannot exclude that some degree of redox-mediated zinc liberation from intracellular ligands, such as metallothioneins (<xref rid="B28" ref-type="bibr">28</xref>), or even extracellular zinc-bound proteins could occur (especially in the <italic>in vivo</italic> situation). Such zinc release could potentially contribute to the SP-mediated T-type channel inhibition, although in the case of intracellular zinc, it would need to be transported to the extracellular space to be able to affect T-type channel activity.</p><p>Clearly, further research is needed to address these intriguing questions; nevertheless, the present study firmly establishes redox-dependent modulation of T-type Ca<sup>2+</sup> channels in nociceptive neurons as a mechanism contributing to the acute anti-nociceptive action of SP in the peripheral nociceptive system.</p></sec><sec sec-type="materials|methods" id="s008"><title>Materials and Methods</title><sec id="s009"><title>Cell culture, transfections, complementary DNA constructs, and chemicals</title><p>DRG neurons from adult male Sprague&#x02013;Dawley rats (170&#x02013;180&#x02009;g) were dissociated as previously described (<xref rid="B13" ref-type="bibr">13</xref>, <xref rid="B29" ref-type="bibr">29</xref>) and cultured in DMEM supplemented with GlutaMax I, 10% fetal calf serum, penicillin (50&#x02009;U/ml), and streptomycin (50&#x02009;&#x003bc;g/ml) on glass coverslips that were coated with poly-<sc>d</sc>-lysine for 2&#x02013;5 days in a humidified incubator (37&#x000b0;C, 5% CO<sub>2</sub>). No growth factors were added to the culture media. HEK 293 cells were cultured in the same DMEM media; cells were passaged every 2 days. Human NK1 receptor (GenBank accession No. AY462098) complementary DNA (cDNA) was from the Missouri Science and Technology cDNA Resource Center. WtCa<sub>V</sub>3.1 (GenBank accession No. AF027984), wtCa<sub>V</sub>3.2 (GenBank accession No. AF051946), Ca<sub>V</sub>3.1Q172H, and Ca<sub>V</sub>3.2H191Q were kindly provided by Dr E. Perez-Reyes (University of Virginia). HEK293 cells were transfected using Lipofectamine 2000 (Invitrogen) according to the manufacturer's instructions. ST101 was synthesized in house; Z944 was from Toronto Research Chemicals; PTX was from Enzo Life Science; and FluoZin-3AM was from Life Technologies. All other chemicals were from Sigma.</p></sec><sec id="s010"><title>siRNA gene silencing</title><p>To knock down Ca<sub>V</sub>3.2, DRGs were dissociated as described (<xref rid="B13" ref-type="bibr">13</xref>); immediately after dissociation, DRG pellets were resuspended in 900&#x02009;&#x003bc;l DMEM (without GlutaMax I, serum or antibiotics), to which a mixture of 9&#x02009;&#x003bc;l Lipofectamine RNAiMAX (Invitrogen) and either a mix of three anti-Cacna1h Stealth siRNAs (RSS350285, RSS350286, RSS350287; Life Technologies; 200&#x02009;n<italic>M</italic> each) or a scrambled control oligo (Stealth RNAi<sup>&#x02122;</sup> siRNA Negative Control; Life Technologies; 200&#x02009;n<italic>M</italic>) were added immediately before resuspension. Cultures were than plated in 50&#x02009;&#x003bc;l droplets onto glass coverslips that were coated with poly-<sc>d</sc>-lysine and incubated for 5&#x02013;6&#x02009;h; the transfection media were then replaced with full DRG culture medium. Patch-clamp recordings were conducted 24&#x02013;48&#x02009;h after the transfection. The following primers were used for reverse transcription polymerase chain reaction (RT-PCR) analysis:
<list list-type="simple"><list-item><p>Cacna1h sense: 5&#x02032;-TGCCCACGGAGTCTATGAGT-3&#x02032;</p></list-item><list-item><p>Cacna1h AS: 5&#x02032;-GTTGTAGGGGTTCCGGATGT-3&#x02032;</p></list-item><list-item><p>Gapdh sense: 5&#x02032;-GACATGCCGCCTGGAGAAAC-3&#x02032;</p></list-item><list-item><p>Gapdh AS: 5&#x02032;-AGCCCAGGATGCCCTTTAGT-3&#x02032;</p></list-item></list></p><p>To knock down G<sub>i/o</sub> or G<sub>q/11</sub> G&#x003b1; subunits, Silencer Select RNAi siRNA (Invitrogen) oligonucleotides were used; the DRG dissociation and transfection were performed as described earlier. A mixture of the siRNA against G<sub>q</sub> and G<sub>11</sub> or against G<sub>i1-3</sub> and G<sub>o</sub> was co-transfected. The following siRNA oligos were used:
<list list-type="simple"><list-item><p>Anti-Gnaq sense: 5&#x02032;-UGACUCUACCAAAUACUAUtt-3&#x02032;</p></list-item><list-item><p>Anti-Gnaq AS: 5&#x02032;-AUAGUAUUUGGUAGAGUCAga-3&#x02032;</p></list-item><list-item><p>Anti-Gna11 sense: 5&#x02032;-GCAUCGCUACAGUAGGCUAtt-3&#x02032;</p></list-item><list-item><p>Anti-Gna11 AS: 5&#x02032;-UAGCCUACUGUAGCGAUGCgg-3&#x02032;</p></list-item><list-item><p>Anti-Gnai1 sense: 5&#x02032;-GAAGCUGUUCGAUAGCAUAtt-3&#x02032;</p></list-item><list-item><p>Anti-Gnai1 AS: 5&#x02032;-UAUGCUAUCGAACAGCUUCat-3&#x02032;</p></list-item><list-item><p>Anti-Gnai2 sense: 5&#x02032;-CAGAGUGACUAUAUCCCUAtt-3&#x02032;</p></list-item><list-item><p>Anti-Gnai2 AS: 5&#x02032;-UAGGGAUAUAGUCACUCUGtg-3&#x02032;</p></list-item><list-item><p>Anti-Gnai3 sense: 5&#x02032;-CAAUGAUUCUGCUUCAUAUtt-3&#x02032;</p></list-item><list-item><p>Anti-Gnai3 AS: 5&#x02032;-AUAUGAAGCAGAAUCAUUGag-3&#x02032;</p></list-item><list-item><p>Anti-Gnao sense1: 5&#x02032;-GCAGAUGAAGAUCAUCCAUtt-3&#x02032;</p></list-item><list-item><p>Anti-Gnao AS1: 5&#x02032;-AUGGAUGAUCUUCAUCUGCtt-3&#x02032;</p></list-item><list-item><p>Anti-Gnao sense2: 5&#x02032;-CCUCCACUUCAGGCUGUUUtt-3&#x02032;</p></list-item><list-item><p>Anti-Gnao AS2: 5&#x02032;-AAACAGCCUGAAGUGGAGGtt-3&#x02032;</p></list-item><list-item><p>The following primers were used for RT-PCR analysis:</p></list-item><list-item><p>Gnaq sense: 5&#x02032;-TCCCAGAATATGATGGACCCC-3&#x02032;;</p></list-item><list-item><p>Gnaq AS: 5&#x02032;-CGGATGTTCTCCGTGTCTGT-3&#x02032;.</p></list-item><list-item><p>Gna11 sense: 5&#x02032;-ACAAGGCCAATGCACTCCTG-3&#x02032;;</p></list-item><list-item><p>Gna11 AS: 5&#x02032;-GGTCCACGTCCGTCAAGTAG-3&#x02032;.</p></list-item><list-item><p>Gnai1 sense: 5&#x02032;-GGATGATGCTCGCCAACTCT-3&#x02032;;</p></list-item><list-item><p>Gnai1 AS: 5&#x02032;-CATTCAGGTAGTACGCCGCC-3&#x02032;.</p></list-item><list-item><p>Gnai2 sense: 5&#x02032;-TACACAGGGGCCAACAAGTAT-3&#x02032;;</p></list-item><list-item><p>Gnai2 AS: 5&#x02032;-CTCACAGGTAGTGGGGAGCA-3&#x02032;.</p></list-item><list-item><p>Gnai3 sense: 5&#x02032;-TGTAGGTGGCCAAAGATCCG-3&#x02032;;</p></list-item><list-item><p>Gnai3 AS: 5&#x02032;-TGCATTCGGTTCATTTCCTCG-3&#x02032;.</p></list-item><list-item><p>Gnao1 sense: 5&#x02032;-AAAGCAAAAACCGCTCACCC-3&#x02032;;</p></list-item><list-item><p>Gnao1 AS: 5&#x02032;-CATGAAGCAGTCAAATAGGTTGC-3&#x02032;.</p></list-item></list></p></sec><sec id="s011"><title>Electrophysiology</title><p>All recordings were made using Multiclamp 700B amplifier in combination with pCLAMP 10.4 software (Molecular Devices). Voltage-clamp recordings from DRG neurons were made using whole-cell patch clamp. The standard bath solution contained the following (in m<italic>M</italic>): 150 TEA-Cl; 2.5 CsCl; 2.5 CaCl<sub>2</sub>; 10 HEPES; 0.5 MgCl<sub>2</sub>; and 10 glucose (pH 7.4 adjusted with CsOH). The standard pipette solution contained the following (in m<italic>M</italic>): 110 CsCl; 3 MgCl<sub>2</sub>; 10 EGTA; 10 HEPES; 3 Mg-ATP; and 0.6 GTP (pH 7.4 adjusted with CsOH). The access resistance was typically within 4&#x02013;8&#x02009;M&#x003a9;. T-type calcium currents (LVA) were measured by 50&#x02009;ms square voltage pulses to &#x02212;40&#x02009;mV from a holding potential of &#x02212;90&#x02009;mV. HVA currents were measured by 200&#x02009;ms square voltage pulses to 0&#x02009;mV from a holding potential of &#x02212;90&#x02009;mV.</p><p>In recordings from HEK 293 cells, amphotericin B-perforated patch-clamp technique was used (<xref rid="B13" ref-type="bibr">13</xref>). The pipette solution contained the following (in m<italic>M</italic>): 155 CsCl; 10 HEPES; 1 EGTA; and 4 MgCl<sub>2</sub> supplemented with amphotericin B (250&#x02009;&#x003bc;g/ml), pH 7.4 adjusted with CsOH. The bath solution was the same as for DRG neuron recordings. The access resistance was typically within 8&#x02013;12&#x02009;M&#x003a9;.</p><p>Voltage-clamp recordings were sampled at 4&#x02009;kHz. Series resistance was compensated online by 50%; the voltage error due to series resistance in our recordings did not exceed 6&#x02009;mV and typically was within &#x0223c;2&#x02009;mV.</p><p>In experiments with H<sub>2</sub>O<sub>2</sub>, 3% agar-salt (3 <italic>M</italic> KCl) bridges were used. Concentration dependence of Ca<sub>V</sub>3.2 channel inhibition by zinc was fit to the two-component logistic function:
<disp-formula><tex-math id="eq1" notation="LaTeX">\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
 { \frac { { I_ { max } } - I }  { { I_ { max } } } } = { \rm { } } { \frac { { \frac { { N_ { \left. { 0 ( Max1 } \right) } } }  { { N_0 } } } }  { 1 + { { \left( { { \frac { I { C_ { \left. { 50 ( 1 } \right) } } }  { \left[ { Z { n^ { 2 + } } } \right] } } } \right) } ^ { nH } } } } + { \rm { } } { \frac { { \frac { { N_ { \left. { 0 ( Max2 } \right) } } }  { { N_0 } } } }  { 1 + { { \left( { { \frac { I { C_ { \left. { 50 ( 2 } \right) } } }  { \left[ { Z { n^ { 2 + } } } \right] } } } \right) } ^ { nH } } } } ,
\end{align*}
\end{document}</tex-math></disp-formula></p><p>where <italic>N</italic><sub>0</sub> is the total amount of zinc-binding sites, <italic>N</italic><sub>0(max1)</sub> is the amount of high-affinity binding sites, <italic>N</italic><sub>0(max2)</sub> is the amount of low-affinity binding sites, <italic>I</italic><sub>max</sub> is the maximal Ca<sub>V</sub>3.2 peak current amplitude, IC<sub>50</sub> is the [Zn<sup>2+</sup>] necessary for half-maximal inhibition, and <italic>nH</italic> is the Hill coefficient. The concentration dependency of the S9SP effect was fit to the one-component logistic function:
<disp-formula><tex-math id="eq2" notation="LaTeX">\documentclass{aastex}\usepackage{amsbsy}\usepackage{amsfonts}\usepackage{amssymb}\usepackage{bm}\usepackage{mathrsfs}\usepackage{pifont}\usepackage{stmaryrd}\usepackage{textcomp}\usepackage{portland, xspace}\usepackage{amsmath, amsxtra}\pagestyle{empty}\DeclareMathSizes{10}{9}{7}{6}\begin{document}
\begin{align*}
{ \rm{y}} = {{ \rm{A}}_{ \rm{2}}} + ( {{ \rm{A}}_{ \rm{1}}} - {{ \rm{A}}_{ \rm{2}}} ) / ( {{ \rm{1}} + {{ ( {x / {x_0}} )}^{nH}}} ),
\end{align*}
\end{document}</tex-math></disp-formula></p><p>where y is the current inhibition; A<sub>1</sub> and A<sub>2</sub> are the maximum and minimum effects, respectively; <italic>x</italic> is the S9SP concentration; and <italic>nH</italic> is the Hill coefficient.</p><p>Neuronal excitability was studied using the amphotericin B-perforated patch-clamp current technique (<xref rid="B13" ref-type="bibr">13</xref>). The extracellular solution contained the following (in m<italic>M</italic>): 160 NaCl, 2.5 KCl, 5 CaCl<sub>2</sub>, 1 MgCl<sub>2</sub>, 10 HEPES, and 8 Glucose. The intracellular solution contained the following (in m<italic>M</italic>): 145 KCl, 15 NaCl, 5 MgCl<sub>2</sub>, 10 HEPES, and 250&#x02009;&#x003bc;g/ml Amphotericin B. The access resistance was typically within 8&#x02013;12&#x02009;m&#x003a9;. APs were generated by an injection of 200 pA current for 1&#x02009;s from a holding current of 0 pA. Rheobase was determined from a train of current steps from 0 to 400 pA delivered in 20-pA increments. Current clamp recordings were sampled at 12.5&#x02009;kHz. Bridge balance adjustments were not applied, since only relative changes in E<sub>rest</sub>, AP number, and rheobase were investigated.</p></sec><sec id="s012"><title>Measurement of zinc concentrations</title><p>The concentrations of zinc in experimental solutions were determined using an automated Ion Channel Reader 8000 flame atomic absorption spectrometer (Aurora Biomed) according to the manufacturer's instructions. To test whether SP induces zinc release from the cultured DRG cells, DRG cultures were grown on 10&#x02009;mm round coverglass in 24-well plates; cultures were washed with extracellular solution (EC) and incubated in 0.5&#x02009;ml EC that was supplemented with 1&#x02009;&#x003bc;<italic>M</italic> S9SP for 2&#x02013;10&#x02009;min; and supernatants were collected and analyzed for zinc content.</p></sec><sec id="s013"><title>Zinc imaging</title><p>Changes in the intracellular zinc levels were evaluated using fluorescence imaging. DRG cultures were loaded with FluoZin-3AM (5&#x02009;&#x003bc;<italic>M</italic> for 30&#x02009;min at 37&#x000b0;C in the presence of 0.02% pluronic F-127). Cells were washed with extracellular bath solution composed of the following (in m<italic>M</italic>): 160 NaCl; 2.5 KCl; 2 CaCl<sub>2</sub>; 1 MgCl<sub>2</sub>; and 10 HEPES (pH 7.4 adjusted with NaOH); they were imaged using a Leica SP5 fluorescence imaging system assembled on a Leica DMI6000 microscope and illuminated with 488&#x02009;nm light for 1200&#x02009;ms (400&#x02009;Hz) with a 2&#x02009;s interval. Solutions were applied using a gravity perfusion system.</p></sec><sec id="s014"><title>Behavioral assays</title><p>Sprague&#x02013;Dawley rats (body weight, 170&#x02013;180&#x02009;g) were grouped randomly and allowed to acclimate for at least 30&#x02009;min in a transparent observation chamber before the experiment. Animals received a 50-&#x003bc;l intraplantar injection of ST101 (0.001&#x02013;10&#x02009;nmol/site), BK (10&#x02009;nmol/site), RTG (1&#x02013;10&#x02009;nmol/site), Z944 (0.05&#x02013;5&#x02009;nmol/site), SP (0.5&#x02013;5&#x02009;nmol/site), or saline, respectively, into the right hind paw. For evaluation of the acute &#x0201c;spontaneous&#x0201d; pain, animals were video-recorded for 30&#x02009;min after the injection and protective (&#x0201c;nocifensive&#x0201d;) behavior was analyzed as time spent licking, biting, lifting, and flinching the injected paw. The analyses were performed by an observer who was unaware of treatment allocations. In the pre-injection experiments, the right hind paw of the animal received a pre-injection of 50&#x02009;&#x003bc;l Z944 (0.05&#x02013;0.5&#x02009;nmol/site), RTG (1&#x02013;10&#x02009;nmol/site), SP (0.5&#x02009;nmol/site), Z944 (0.05&#x02013;0.5&#x02009;nmol/site)+RTG (1&#x02009;nmol/site), or saline; 5&#x02009;min later, on the same paw, the animal received a further 50-&#x003bc;l injection of BK (10&#x02009;nmol/site) together with the pre-injection drug mix. Nocifensive behavior was analyzed as described earlier.</p><p>For measurement of thermal hyperalgesia, the change in the latency of hind-paw withdrawal in response to noxious heat was recorded using the Hargreaves&#x02019; plantar method (Ugo Basile) at 8&#x02009;min after the hind-paw injection of drugs; the heat source was set to 25% of the maximal intensity.</p><p>For measurement of sensitivity to gentle touch and mechanical hyperalgesia, two methods were used. (i) Cotton swab test was performed as previously described (<xref rid="B53" ref-type="bibr">53</xref>). Briefly, rats were allowed to acclimate in a cage with a wire mesh bottom for at least 30&#x02009;min and then were manually probed with a &#x0201c;cotton swab&#x0201d; pulled from a Q-tip (to approximately three times the original size). A swab was applied in a sweeping motion underneath the rats&#x02019; paws, and the withdrawal responses were recorded. Five sweeps were applied in each test, with at least 10&#x02009;s between each sweep; withdrawal score was calculated as a percentage of positive responses. (ii) The von Frey test was performed using a calibrated range of filaments with different bending forces (2, 4, 6, 8, 10, and 15&#x02009;g; Stoelting Co.). A single filament was applied perpendicularly to the plantar surface of the hind paw for five times, with an interval of 5&#x02009;s, and it was scored for withdrawal responses. Each force was probed five times, the number of withdrawals out of five trials was counted, and the percentage of withdrawal responses was calculated. Both types of assays were performed 8&#x02009;min after the hind-paw drug injection.</p></sec><sec id="s015"><title>Intrathecal administration of ODNs targeting Ca<sub>V</sub>3.2 subunit</title><p>The <italic>in vivo</italic> Ca<sub>V</sub>3.2 knock-down was performed as described earlier (<xref rid="B3" ref-type="bibr">3</xref>) by using the same ODN sequences that were synthesized by SBS Genetech. AS ODNs had the following sequence: CCACCTTCTTACGCCAGCGG. The mismatch ODNs of the following sequence were used as a negative control: TACTGTACTTGCGAGGCCAC. The mismatch ODN was not complementary to any known nucleotide sequence. ODNs were reconstituted in saline before injection. ODNs (12.5&#x02009;&#x003bc;g/rat in 10&#x02009;&#x003bc;l of saline) or saline were injected intrathecally (i.t.) between the L5 and L6 dorsal spinous processes as described earlier (<xref rid="B3" ref-type="bibr">3</xref>, <xref rid="B42" ref-type="bibr">42</xref>) under isoflurane anesthesia. The treatment was repeated twice daily for 4 days. The pain tests were performed on the next day after the last injection. After behavioral testing, animals were humanly sacrificed; lumbar DRGs were extracted and analyzed for the knock-down efficiency by comparing the <italic>Cacna1h</italic> mRNA levels in lumbar (L4 to L6) DRGs of the saline-injected, mismatch ODN-injected, and AS ODN-injected animals using RT-PCR. The same <italic>Cacna1h</italic> and <italic>Gapdh</italic> primers as in siRNA experiments were used for RT-PCR.</p></sec><sec id="s016"><title>Reagents</title><p>Signaling peptide bradykinin (Arg-Pro-Pro-Gly-Phe-Ser-Pro-Phe-Arg; BK; Sigma); NK1-selective tachykinin receptor agonists [Sar9]-Substance P (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met-NH<sub>2</sub>; S9SP; Sigma) and [Sar<sup>9</sup>, Met(O<sub>2</sub>)<sup>11</sup>]-Substance P (Arg-Pro-Lys-Pro-Gln-Gln-Phe-Phe-Sar-Leu-Met[O<sub>2</sub>]-NH2; S9M11SP; synthesized by SBS Genetech); NK1-selective antagonist CP-99994 (Sigma); reducing agent DTT (Sigma); G<sub>i/o</sub> pathway inhibitor PTX (Sigma); M-type channel opener RTG (synthesized in house); VGCC blocker MIB (Sigma); T-type specific Ca<sup>2+</sup> channel blocker Z944 (synthesized in house); cognitive enhancer and T-type Ca<sup>2+</sup> channel activator ST101 (synthesized in house); zinc chelator TPEN (Sigma); and protein kinase C inhibitor, BIM I were used as reagents.</p></sec><sec id="s017"><title>Statistics</title><p>All data are given as mean &#x000b1; standard error of the mean. Differences between groups were assessed by Student's <italic>t</italic> test (paired or unpaired, as appropriate) or one-way analysis of variance (ANOVA) with Bonferroni correction. Behavioral experiments were analyzed using Kruskal&#x02013;Wallis ANOVA; difference between groups was analyzed with Mann&#x02013;Whitney test. The effects of the drugs on neuronal excitability were analyzed using either paired <italic>t</italic> test or paired Wilcoxon signed ranks test (for data sets that failed normality test). The differences were considered significant at <italic>p</italic>&#x02009;&#x02264;&#x02009;0.05. Statistical analyses were performed using Origin 8.6 (OriginLab Corporation).</p></sec></sec><sec sec-type="supplementary-material"><title>Supplementary Material</title><supplementary-material content-type="local-data" id="SD1"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="eps" xlink:href="Supp_Fig1.eps" orientation="portrait" xlink:type="simple" id="d38e3719" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD2"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="eps" xlink:href="Supp_Fig2.eps" orientation="portrait" xlink:type="simple" id="d38e3724" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD3"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="eps" xlink:href="Supp_Fig3.eps" orientation="portrait" xlink:type="simple" id="d38e3729" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD4"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="eps" xlink:href="Supp_Fig4.eps" orientation="portrait" xlink:type="simple" id="d38e3734" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD5"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="eps" xlink:href="Supp_Fig5.eps" orientation="portrait" xlink:type="simple" id="d38e3739" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD6"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="eps" xlink:href="Supp_Fig7.eps" orientation="portrait" xlink:type="simple" id="d38e3744" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD7"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="eps" xlink:href="Supp_Fig6.eps" orientation="portrait" xlink:type="simple" id="d38e3749" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD8"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="eps" xlink:href="Supp_Fig8.eps" orientation="portrait" xlink:type="simple" id="d38e3754" position="anchor"/></supplementary-material><supplementary-material content-type="local-data" id="SD9"><caption><title>Supplemental data</title></caption><media mimetype="application" mime-subtype="eps" xlink:href="Supp_Fig9.eps" orientation="portrait" xlink:type="simple" id="d38e3759" position="anchor"/></supplementary-material></sec></body><back><sec id="s018" sec-type="ack"><title>Acknowledgments</title><p>The authors thank Han Hao and Yuan Wang for expert technical assistance, Hongchao Men for help with immunohistochemistry, and Bingcai Guan for advice on electrophysiology. This work was supported by the National Natural Science Foundation of China (Grant Nos. 31270882 to H.Z., 31571088 to X.D., and 81201642 to H.G.), the National Basic Research Program (Grant No. 2013CB531302 to H.Z.), and MRC (Grant Nos. G1002183 to N.G. and MR/K021303/1 to C.P. and N.G.).</p></sec><sec id="s019"><title>Author Disclosure Statement</title><p>No competing financial interests exist.</p></sec><ref-list content-type="parsed"><title>References</title><ref id="B1"><label>1</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Abdulla</surname><given-names>FA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stebbing</surname><given-names>MJ</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Smith</surname><given-names>PA</given-names></name></person-group>
<article-title>Effects of substance P on excitability and ionic currents of normal and axotomized rat dorsal root ganglion neurons</article-title>. <source>Eur J Neurosci</source>
<volume>13</volume>: <fpage>545</fpage>&#x02013;<lpage>552</lpage>, <year>2001</year><pub-id pub-id-type="pmid">11168562</pub-id></mixed-citation></ref><ref id="B2"><label>2</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ayoola</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hwang</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hong</surname><given-names>SJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rose</surname><given-names>KE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boyd</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bozic</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Park</surname><given-names>JY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Osuru</surname><given-names>HP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>DiGruccio</surname><given-names>MR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Covey</surname><given-names>DF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jevtovic-Todorovic</surname><given-names>V</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>
<article-title>Inhibition of Ca<sub>V</sub>3.2 T-type calcium channels in peripheral sensory neurons contributes to analgesic properties of epipregnanolone</article-title>. <source>Psychopharmacology (Berl)</source>
<volume>231</volume>: <fpage>3503</fpage>&#x02013;<lpage>3515</lpage>, <year>2014</year><pub-id pub-id-type="pmid">24800894</pub-id></mixed-citation></ref><ref id="B3"><label>3</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Bourinet</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Alloui</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Monteil</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barrere</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Couette</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Poirot</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pages</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>McRory</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Snutch</surname><given-names>TP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Eschalier</surname><given-names>A</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Nargeot</surname><given-names>J</given-names></name></person-group>
<article-title>Silencing of the Cav3.2 T-type calcium channel gene in sensory neurons demonstrates its major role in nociception</article-title>. <source>EMBO J</source>
<volume>24</volume>: <fpage>315</fpage>&#x02013;<lpage>324</lpage>, <year>2005</year><pub-id pub-id-type="pmid">15616581</pub-id></mixed-citation></ref><ref id="B4"><label>4</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Boycott</surname><given-names>HE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dallas</surname><given-names>ML</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Elies</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pettinger</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boyle</surname><given-names>JP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Scragg</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Peers</surname><given-names>C</given-names></name></person-group>
<article-title>Carbon monoxide inhibition of Cav3.2 T-type Ca<sup>2+</sup> channels reveals tonic modulation by thioredoxin</article-title>. <source>FASEB J</source>
<volume>27</volume>: <fpage>3395</fpage>&#x02013;<lpage>3407</lpage>, <year>2013</year><pub-id pub-id-type="pmid">23671274</pub-id></mixed-citation></ref><ref id="B5"><label>5</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Brown</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Maggio</surname><given-names>JE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vigna</surname><given-names>SR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mantyh</surname><given-names>PW</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Basbaum</surname><given-names>AI</given-names></name></person-group>
<article-title>Morphological characterization of substance P receptor-immunoreactive neurons in the rat spinal cord and trigeminal nucleus caudalis</article-title>. <source>J Comp Neurol</source>
<volume>356</volume>: <fpage>327</fpage>&#x02013;<lpage>344</lpage>, <year>1995</year><pub-id pub-id-type="pmid">7642798</pub-id></mixed-citation></ref><ref id="B6"><label>6</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Busselberg</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Michael</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Evans</surname><given-names>ML</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Carpenter</surname><given-names>DO</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Haas</surname><given-names>HL</given-names></name></person-group>
<article-title>Zinc (Zn<sup>2+</sup>) blocks voltage gated calcium channels in cultured rat dorsal root ganglion cells</article-title>. <source>Brain Res</source>
<volume>593</volume>: <fpage>77</fpage>&#x02013;<lpage>81</lpage>, <year>1992</year><pub-id pub-id-type="pmid">1333873</pub-id></mixed-citation></ref><ref id="B7"><label>7</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Cang</surname><given-names>CL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YQ</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Zhao</surname><given-names>ZQ</given-names></name></person-group>
<article-title>PKCepsilon-dependent potentiation of TTX-resistant Nav1.8 current by neurokinin-1 receptor activation in rat dorsal root ganglion neurons</article-title>. <source>Mol Pain</source>
<volume>5</volume>: <fpage>33</fpage>, <year>2009</year><pub-id pub-id-type="pmid">19563686</pub-id></mixed-citation></ref><ref id="B8"><label>8</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Catterall</surname><given-names>WA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Snutch</surname><given-names>TP</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Striessnig</surname><given-names>J</given-names></name></person-group>
<article-title>International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels</article-title>. <source>Pharmacol Rev</source>
<volume>57</volume>: <fpage>411</fpage>&#x02013;<lpage>425</lpage>, <year>2005</year><pub-id pub-id-type="pmid">16382099</pub-id></mixed-citation></ref><ref id="B9"><label>9</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Chen</surname><given-names>CC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lamping</surname><given-names>KG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nuno</surname><given-names>DW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barresi</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Prouty</surname><given-names>SJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lavoie</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cribbs</surname><given-names>LL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>England</surname><given-names>SK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sigmund</surname><given-names>CD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weiss</surname><given-names>RM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Williamson</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hill</surname><given-names>JA</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Campbell</surname><given-names>KP</given-names></name></person-group>
<article-title>Abnormal coronary function in mice deficient in alpha1H T-type Ca<sup>2+</sup> channels</article-title>. <source>Science</source>
<volume>302</volume>: <fpage>1416</fpage>&#x02013;<lpage>1418</lpage>, <year>2003</year><pub-id pub-id-type="pmid">14631046</pub-id></mixed-citation></ref><ref id="B10"><label>10</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Choe</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Messinger</surname><given-names>RB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Leach</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Eckle</surname><given-names>VS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Obradovic</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Salajegheh</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jevtovic-Todorovic</surname><given-names>V</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>
<article-title>TTA-P2 is a potent and selective blocker of T-type calcium channels in rat sensory neurons and a novel antinociceptive agent</article-title>. <source>Mol Pharmacol</source>
<volume>80</volume>: <fpage>900</fpage>&#x02013;<lpage>910</lpage>, <year>2011</year><pub-id pub-id-type="pmid">21821734</pub-id></mixed-citation></ref><ref id="B11"><label>11</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Coste</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Crest</surname><given-names>M</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Delmas</surname><given-names>P</given-names></name></person-group>
<article-title>Pharmacological dissection and distribution of NaN/Nav1.9, T-type Ca<sup>2+</sup> currents, and mechanically activated cation currents in different populations of DRG neurons</article-title>. <source>J Gen Physiol</source>
<volume>129</volume>: <fpage>57</fpage>&#x02013;<lpage>77</lpage>, <year>2007</year><pub-id pub-id-type="pmid">17190903</pub-id></mixed-citation></ref><ref id="B12"><label>12</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>De Biasi</surname><given-names>S</given-names></name></person-group> and <person-group person-group-type="author"><name><surname>Rustioni</surname><given-names>A</given-names></name></person-group>
<article-title>Glutamate and substance P coexist in primary afferent terminals in the superficial laminae of spinal cord</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>85</volume>: <fpage>7820</fpage>&#x02013;<lpage>7824</lpage>, <year>1988</year><pub-id pub-id-type="pmid">2459717</pub-id></mixed-citation></ref><ref id="B13"><label>13</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Du</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hao</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gigout</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sundt</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jaffe</surname><given-names>DB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>
<article-title>Control of somatic membrane potential in nociceptive neurons and its implications for peripheral nociceptive transmission</article-title>. <source>Pain</source>
<volume>155</volume>: <fpage>2306</fpage>&#x02013;<lpage>2322</lpage>, <year>2014</year><pub-id pub-id-type="pmid">25168672</pub-id></mixed-citation></ref><ref id="B14"><label>14</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elies</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Scragg</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boyle</surname><given-names>JP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Peers</surname><given-names>C</given-names></name></person-group>
<article-title>Regulation of the T-type Ca channel Cav3.2 by hydrogen sulfide: Emerging controversies concerning the role of H S in nociception</article-title>. <source>J Physiol</source>
<year>2016</year> [Epub ahead of print]; DOI: <pub-id pub-id-type="doi">10.1113/JP270963</pub-id></mixed-citation></ref><ref id="B15"><label>15</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Elies</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Scragg</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dallas</surname><given-names>ML</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>MacDougall</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boyle</surname><given-names>JP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Peers</surname><given-names>C</given-names></name></person-group>
<article-title>Hydrogen sulfide inhibits Cav3.2 T-type Ca<sup>2+</sup> channels</article-title>. <source>FASEB J</source>
<volume>28</volume>: <fpage>5376</fpage>&#x02013;<lpage>5387</lpage>, <year>2014</year><pub-id pub-id-type="pmid">25183670</pub-id></mixed-citation></ref><ref id="B16"><label>16</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Flegel</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schobel</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Altmuller</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Becker</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tannapfel</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hatt</surname><given-names>H</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Gisselmann</surname><given-names>G</given-names></name></person-group>
<article-title>RNA-Seq analysis of human trigeminal and dorsal root ganglia with a focus on chemoreceptors</article-title>. <source>PLoS One</source>
<volume>10</volume>: <fpage>e0128951</fpage>, <year>2015</year><pub-id pub-id-type="pmid">26070209</pub-id></mixed-citation></ref><ref id="B17"><label>17</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francois</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kerckhove</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Meleine</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Alloui</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barrere</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gelot</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Uebele</surname><given-names>VN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Renger</surname><given-names>JJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Eschalier</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ardid</surname><given-names>D</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Bourinet</surname><given-names>E</given-names></name></person-group>
<article-title>State-dependent properties of a new T-type calcium channel blocker enhance Ca<sub>V</sub>3.2 selectivity and support analgesic effects</article-title>. <source>Pain</source>
<volume>154</volume>: <fpage>283</fpage>&#x02013;<lpage>293</lpage>, <year>2013</year><pub-id pub-id-type="pmid">23257507</pub-id></mixed-citation></ref><ref id="B18"><label>18</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Francois</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schuetter</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Laffray</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sanguesa</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pizzoccaro</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dubel</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mantilleri</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nargeot</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Noel</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wood</surname><given-names>JN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moqrich</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pongs</surname><given-names>O</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Bourinet</surname><given-names>E</given-names></name></person-group>
<article-title>The low-threshold calcium channel Cav3.2 determines low-threshold mechanoreceptor function</article-title>. <source>Cell Rep</source> pii: <!--<pub-id pub-id-type="pii">S2211-1247(14)01095-X</pub-id>-->, <year>2015</year></mixed-citation></ref><ref id="B19"><label>19</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zaika</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Martin</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hernandez</surname><given-names>CC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez</surname><given-names>MR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>AY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jaffe</surname><given-names>DB</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Shapiro</surname><given-names>MS</given-names></name></person-group>
<article-title>Oxidative modification of M-type K<sup>+</sup> channels as a mechanism of cytoprotective neuronal silencing</article-title>. <source>EMBO J</source>
<volume>25</volume>: <fpage>4996</fpage>&#x02013;<lpage>5004</lpage>, <year>2006</year><pub-id pub-id-type="pmid">17024175</pub-id></mixed-citation></ref><ref id="B20"><label>20</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Garcia-Caballero</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gadotti</surname><given-names>VM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stemkowski</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weiss</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Souza</surname><given-names>IA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hodgkinson</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bladen</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamid</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pizzoccaro</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Deage</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Francois</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bourinet</surname><given-names>E</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Zamponi</surname><given-names>GW</given-names></name></person-group>
<article-title>The deubiquitinating enzyme USP5 modulates neuropathic and inflammatory pain by enhancing Cav3.2 channel activity</article-title>. <source>Neuron</source>
<volume>83</volume>: <fpage>1144</fpage>&#x02013;<lpage>1158</lpage>, <year>2014</year><pub-id pub-id-type="pmid">25189210</pub-id></mixed-citation></ref><ref id="B21"><label>21</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hayashi</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Iwata</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tsuchimori</surname><given-names>N</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Matsumoto</surname><given-names>T</given-names></name></person-group>
<article-title>Activation of peripheral KCNQ channels attenuates inflammatory pain</article-title>. <source>Mol Pain</source>
<volume>10</volume>: <fpage>15</fpage>, <year>2014</year><pub-id pub-id-type="pmid">24555569</pub-id></mixed-citation></ref><ref id="B22"><label>22</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Hill</surname><given-names>R</given-names></name></person-group>
<article-title>NK1 (substance P) receptor antagonists &#x02013; Why are they not analgesic in humans?</article-title>
<source>Trends Pharmacol Sci</source>
<volume>21</volume>: <fpage>244</fpage>&#x02013;<lpage>246</lpage>, <year>2000</year><pub-id pub-id-type="pmid">10871891</pub-id></mixed-citation></ref><ref id="B23"><label>23</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Iftinca</surname><given-names>MC</given-names></name></person-group> and <person-group person-group-type="author"><name><surname>Zamponi</surname><given-names>GW</given-names></name></person-group>
<article-title>Regulation of neuronal T-type calcium channels</article-title>. <source>Trends Pharmacol Sci</source>
<volume>30</volume>: <fpage>32</fpage>&#x02013;<lpage>40</lpage>, <year>2009</year><pub-id pub-id-type="pmid">19042038</pub-id></mixed-citation></ref><ref id="B24"><label>24</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jevtovic-Todorovic</surname><given-names>V</given-names></name></person-group> and <person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>
<article-title>The role of peripheral T-type calcium channels in pain transmission</article-title>. <source>Cell Calcium</source>
<volume>40</volume>: <fpage>197</fpage>&#x02013;<lpage>203</lpage>, <year>2006</year><pub-id pub-id-type="pmid">16777222</pub-id></mixed-citation></ref><ref id="B25"><label>25</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Jin</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shah</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lees</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fu</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lippiat</surname><given-names>JD</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Beech</surname><given-names>DJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sivaprasadarao</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Baldwin</surname><given-names>SA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>
<article-title>Activation of the Cl<sup>&#x02212;</sup> channel ANO1 by localized calcium signals in nociceptive sensory neurons requires coupling with the IP<sub>3</sub> receptor</article-title>. <source>Sci Signal</source>
<volume>6</volume>: <fpage>ra73</fpage>, <year>2013</year><pub-id pub-id-type="pmid">23982204</pub-id></mixed-citation></ref><ref id="B26"><label>26</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>HW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Park</surname><given-names>JY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jeong</surname><given-names>SW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kim</surname><given-names>JA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moon</surname><given-names>HJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name></person-group>
<article-title>A molecular determinant of nickel inhibition in Cav3.2 T-type calcium channels</article-title>. <source>J Biol Chem</source>
<volume>281</volume>: <fpage>4823</fpage>&#x02013;<lpage>4830</lpage>, <year>2006</year><pub-id pub-id-type="pmid">16377633</pub-id></mixed-citation></ref><ref id="B27"><label>27</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kang</surname><given-names>HW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vitko</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>SS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name></person-group>
<article-title>Structural determinants of the high affinity extracellular zinc binding site on Cav3.2 T-type calcium channels</article-title>. <source>J Biol Chem</source>
<volume>285</volume>: <fpage>3271</fpage>&#x02013;<lpage>3281</lpage>, <year>2010</year><pub-id pub-id-type="pmid">19940152</pub-id></mixed-citation></ref><ref id="B28"><label>28</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kiedrowski</surname><given-names>L</given-names></name></person-group>
<article-title>Proton-dependent zinc release from intracellular ligands</article-title>. <source>J Neurochem</source>
<volume>130</volume>: <fpage>87</fpage>&#x02013;<lpage>96</lpage>, <year>2014</year><pub-id pub-id-type="pmid">24606401</pub-id></mixed-citation></ref><ref id="B29"><label>29</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Kirton</surname><given-names>HM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pettinger</surname><given-names>L</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>
<article-title>Transient overexpression of genes in neurons using nucleofection</article-title>. <source>Methods Mol Biol</source>
<volume>998</volume>: <fpage>55</fpage>&#x02013;<lpage>64</lpage>, <year>2013</year><pub-id pub-id-type="pmid">23529420</pub-id></mixed-citation></ref><ref id="B30"><label>30</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Krezel</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lesniak</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jezowska-Bojczuk</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mlynarz</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Brasun</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kozlowski</surname><given-names>H</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Bal</surname><given-names>W</given-names></name></person-group>
<article-title>Coordination of heavy metals by dithiothreitol, a commonly used thiol group protectant</article-title>. <source>J Inorg Biochem</source>
<volume>84</volume>: <fpage>77</fpage>&#x02013;<lpage>88</lpage>, <year>2001</year><pub-id pub-id-type="pmid">11330484</pub-id></mixed-citation></ref><ref id="B31"><label>31</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lee</surname><given-names>M</given-names></name></person-group>
<article-title>Z944: A first in class T-type calcium channel modulator for the treatment of pain</article-title>. <source>J Peripher Nerv Syst</source>
<volume>19</volume><issue>Suppl 2</issue>: <fpage>S11</fpage>&#x02013;<lpage>S12</lpage>, <year>2014</year><pub-id pub-id-type="pmid">25269728</pub-id></mixed-citation></ref><ref id="B32"><label>32</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Lin</surname><given-names>CC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>WN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>CJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lin</surname><given-names>YW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zimmer</surname><given-names>A</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Chen</surname><given-names>CC</given-names></name></person-group>
<article-title>An antinociceptive role for substance P in acid-induced chronic muscle pain</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>109</volume>: <fpage>E76</fpage>&#x02013;<lpage>E83</lpage>, <year>2012</year><pub-id pub-id-type="pmid">22084095</pub-id></mixed-citation></ref><ref id="B33"><label>33</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linley</surname><given-names>JE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ooi</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pettinger</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kirton</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boyle</surname><given-names>JP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Peers</surname><given-names>C</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>
<article-title>Reactive oxygen species are second messengers of neurokinin signaling in peripheral sensory neurons</article-title>. <source>Proc Natl Acad Sci U S A</source>
<volume>109</volume>: <fpage>E1578</fpage>&#x02013;<lpage>E1586</lpage>, <year>2012</year><pub-id pub-id-type="pmid">22586118</pub-id></mixed-citation></ref><ref id="B34"><label>34</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linley</surname><given-names>JE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pettinger</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Huang</surname><given-names>D</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>
<article-title>M channel enhancers and physiological M channel block</article-title>. <source>J Physiol</source>
<volume>590</volume>: <fpage>793</fpage>&#x02013;<lpage>807</lpage>, <year>2012</year><pub-id pub-id-type="pmid">22155935</pub-id></mixed-citation></ref><ref id="B35"><label>35</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Linley</surname><given-names>JE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rose</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Patil</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Robertson</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Akopian</surname><given-names>AN</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>
<article-title>Inhibition of M current in sensory neurons by exogenous proteases: A signaling pathway mediating inflammatory nociception</article-title>. <source>J Neurosci</source>
<volume>28</volume>: <fpage>11240</fpage>&#x02013;<lpage>11249</lpage>, <year>2008</year><pub-id pub-id-type="pmid">18971466</pub-id></mixed-citation></ref><ref id="B36"><label>36</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Liu</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Linley</surname><given-names>JE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Du</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ooi</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Gamper</surname><given-names>N</given-names></name></person-group>
<article-title>The acute nociceptive signals induced by bradykinin in rat sensory neurons are mediated by inhibition of M-type K<sup>+</sup> channels and activation of Ca<sup>2+</sup>-activated Cl<sup>-</sup> channels</article-title>. <source>J Clin Invest</source>
<volume>120</volume>: <fpage>1240</fpage>&#x02013;<lpage>1252</lpage>, <year>2010</year><pub-id pub-id-type="pmid">20335661</pub-id></mixed-citation></ref><ref id="B37"><label>37</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Macdonald</surname><given-names>SG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dumas</surname><given-names>JJ</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Boyd</surname><given-names>ND</given-names></name></person-group>
<article-title>Chemical cross-linking of the substance P (NK-1) receptor to the alpha subunits of the G proteins G<sub>q</sub> and G<sub>11</sub></article-title>. <source>Biochemistry</source>
<volume>35</volume>: <fpage>2909</fpage>&#x02013;<lpage>2916</lpage>, <year>1996</year><pub-id pub-id-type="pmid">8608128</pub-id></mixed-citation></ref><ref id="B38"><label>38</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Malcangio</surname><given-names>M</given-names></name></person-group> and <person-group person-group-type="author"><name><surname>Bowery</surname><given-names>NG</given-names></name></person-group>
<article-title>Peptide autoreceptors: Does an autoreceptor for substance P exist?</article-title>
<source>Trends Pharmacol Sci</source>
<volume>20</volume>: <fpage>405</fpage>&#x02013;<lpage>407</lpage>, <year>1999</year><pub-id pub-id-type="pmid">10577252</pub-id></mixed-citation></ref><ref id="B39"><label>39</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Manteniotis</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lehmann</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Flegel</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vogel</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hofreuter</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schreiner</surname><given-names>BS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Altmuller</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Becker</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Schobel</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hatt</surname><given-names>H</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Gisselmann</surname><given-names>G</given-names></name></person-group>
<article-title>Comprehensive RNA-Seq expression analysis of sensory ganglia with a focus on ion channels and GPCRs in Trigeminal ganglia</article-title>. <source>PLoS One</source>
<volume>8</volume>: <fpage>e79523</fpage>, <year>2013</year><pub-id pub-id-type="pmid">24260241</pub-id></mixed-citation></ref><ref id="B40"><label>40</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>McMahon</surname><given-names>SB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bennet</surname><given-names>DLH</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Bevan</surname><given-names>S</given-names></name></person-group>
<article-title>Inflammatory mediators and modulators</article-title>. In: <source>Wall and Melzack's Textbook of Pain</source>, edited by <person-group person-group-type="editor"><name><surname>McMahon</surname><given-names>SB</given-names></name></person-group> and <person-group person-group-type="editor"><name><surname>Koltzenburg</surname><given-names>M.</given-names></name></person-group>
<publisher-loc>Edinburgh</publisher-loc>: <publisher-name>Elsevier Churchill Livingstone</publisher-name>, <year>2006</year>, pp. <fpage>49</fpage>&#x02013;<lpage>72</lpage></mixed-citation></ref><ref id="B41"><label>41</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Messinger</surname><given-names>RB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Naik</surname><given-names>AK</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jagodic</surname><given-names>MM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nelson</surname><given-names>MT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>WY</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Choe</surname><given-names>WJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Orestes</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Latham</surname><given-names>JR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Jevtovic-Todorovic</surname><given-names>V</given-names></name></person-group>
<article-title>In vivo silencing of the Ca<sub>V</sub>3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy</article-title>. <source>Pain</source>
<volume>145</volume>: <fpage>184</fpage>&#x02013;<lpage>195</lpage>, <year>2009</year><pub-id pub-id-type="pmid">19577366</pub-id></mixed-citation></ref><ref id="B42"><label>42</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Mestre</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pelissier</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fialip</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wilcox</surname><given-names>G</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Eschalier</surname><given-names>A</given-names></name></person-group>
<article-title>A method to perform direct transcutaneous intrathecal injection in rats</article-title>. <source>J Pharmacol Toxicol Methods</source>
<volume>32</volume>: <fpage>197</fpage>&#x02013;<lpage>200</lpage>, <year>1994</year><pub-id pub-id-type="pmid">7881133</pub-id></mixed-citation></ref><ref id="B43"><label>43</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Meza</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thapliyal</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bannister</surname><given-names>RA</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Adams</surname><given-names>BA</given-names></name></person-group>
<article-title>Neurokinin 1 receptors trigger overlapping stimulation and inhibition of Ca<sub>V</sub>2.3 (R-type) calcium channels</article-title>. <source>Mol Pharmacol</source>
<volume>71</volume>: <fpage>284</fpage>&#x02013;<lpage>293</lpage>, <year>2007</year><pub-id pub-id-type="pmid">17050807</pub-id></mixed-citation></ref><ref id="B44"><label>44</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moran</surname><given-names>VH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Stammers</surname><given-names>AL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Medina</surname><given-names>MW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Patel</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dykes</surname><given-names>F</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Souverein</surname><given-names>OW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dullemeijer</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez-Rodrigo</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Serra-Majem</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nissensohn</surname><given-names>M</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Lowe</surname><given-names>NM</given-names></name></person-group>
<article-title>The relationship between zinc intake and serum/plasma zinc concentration in children: A systematic review and dose-response meta-analysis</article-title>. <source>Nutrients</source>
<volume>4</volume>: <fpage>841</fpage>&#x02013;<lpage>858</lpage>, <year>2012</year><pub-id pub-id-type="pmid">23016120</pub-id></mixed-citation></ref><ref id="B45"><label>45</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Moriguchi</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shioda</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yamamoto</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Tagashira</surname><given-names>H</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Fukunaga</surname><given-names>K</given-names></name></person-group>
<article-title>The T-type voltage-gated calcium channel as a molecular target of the novel cognitive enhancer ST101: Enhancement of long-term potentiation and CaMKII autophosphorylation in rat cortical slices</article-title>. <source>J Neurochem</source>
<volume>121</volume>: <fpage>44</fpage>&#x02013;<lpage>53</lpage>, <year>2012</year><pub-id pub-id-type="pmid">22251222</pub-id></mixed-citation></ref><ref id="B46"><label>46</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>MT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Joksovic</surname><given-names>PM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>
<article-title>The endogenous redox agent L-cysteine induces T-type Ca<sup>2+</sup> channel-dependent sensitization of a novel subpopulation of rat peripheral nociceptors</article-title>. <source>J Neurosci</source>
<volume>25</volume>: <fpage>8766</fpage>&#x02013;<lpage>8775</lpage>, <year>2005</year><pub-id pub-id-type="pmid">16177046</pub-id></mixed-citation></ref><ref id="B47"><label>47</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>MT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Joksovic</surname><given-names>PM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Su</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kang</surname><given-names>HW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Van Deusen</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Baumgart</surname><given-names>JP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>David</surname><given-names>LS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Snutch</surname><given-names>TP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barrett</surname><given-names>PQ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zorumski</surname><given-names>CF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>
<article-title>Molecular mechanisms of subtype-specific inhibition of neuronal T-type calcium channels by ascorbate</article-title>. <source>J Neurosci</source>
<volume>27</volume>: <fpage>12577</fpage>&#x02013;<lpage>12583</lpage>, <year>2007</year><pub-id pub-id-type="pmid">18003836</pub-id></mixed-citation></ref><ref id="B48"><label>48</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Nelson</surname><given-names>MT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Woo</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kang</surname><given-names>HW</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Vitko</surname><given-names>I</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Barrett</surname><given-names>PQ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Shin</surname><given-names>HS</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>
<article-title>Reducing agents sensitize C-type nociceptors by relieving high-affinity zinc inhibition of T-type calcium channels</article-title>. <source>J Neurosci</source>
<volume>27</volume>: <fpage>8250</fpage>&#x02013;<lpage>8260</lpage>, <year>2007</year><pub-id pub-id-type="pmid">17670971</pub-id></mixed-citation></ref><ref id="B49"><label>49</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Orestes</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bojadzic</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Leach</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Salajegheh</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Digruccio</surname><given-names>MR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nelson</surname><given-names>MT</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>
<article-title>Free radical signalling underlies inhibition of Ca<sub>V</sub>3.2 T-type calcium channels by nitrous oxide in the pain pathway</article-title>. <source>J Physiol</source>
<volume>589</volume>: <fpage>135</fpage>&#x02013;<lpage>148</lpage>, <year>2011</year><pub-id pub-id-type="pmid">21059758</pub-id></mixed-citation></ref><ref id="B50"><label>50</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Passmore</surname><given-names>GM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reilly</surname><given-names>JM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Thakur</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Keasberry</surname><given-names>VN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Marsh</surname><given-names>SJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dickenson</surname><given-names>AH</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Brown</surname><given-names>DA</given-names></name></person-group>
<article-title>Functional significance of M-type potassium channels in nociceptive cutaneous sensory endings</article-title>. <source>Front Mol Neurosci</source>
<volume>5</volume>: <fpage>63</fpage>, <year>2012</year><pub-id pub-id-type="pmid">22593734</pub-id></mixed-citation></ref><ref id="B51"><label>51</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>
<article-title>Molecular physiology of low-voltage-activated t-type calcium channels</article-title>. <source>Physiol Rev</source>
<volume>83</volume>: <fpage>117</fpage>&#x02013;<lpage>161</lpage>, <year>2003</year><pub-id pub-id-type="pmid">12506128</pub-id></mixed-citation></ref><ref id="B52"><label>52</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Petho</surname><given-names>G</given-names></name></person-group> and <person-group person-group-type="author"><name><surname>Reeh</surname><given-names>PW</given-names></name></person-group>
<article-title>Sensory and signaling mechanisms of bradykinin, eicosanoids, platelet-activating factor, and nitric oxide in peripheral nociceptors</article-title>. <source>Physiol Rev</source>
<volume>92</volume>: <fpage>1699</fpage>&#x02013;<lpage>1775</lpage>, <year>2012</year><pub-id pub-id-type="pmid">23073630</pub-id></mixed-citation></ref><ref id="B53"><label>53</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Ranade</surname><given-names>SS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Woo</surname><given-names>SH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dubin</surname><given-names>AE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Moshourab</surname><given-names>RA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wetzel</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Petrus</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mathur</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Begay</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Coste</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mainquist</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wilson</surname><given-names>AJ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Francisco</surname><given-names>AG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Reddy</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Qiu</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wood</surname><given-names>JN</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lewin</surname><given-names>GR</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Patapoutian</surname><given-names>A</given-names></name></person-group>
<article-title>Piezo2 is the major transducer of mechanical forces for touch sensation in mice</article-title>. <source>Nature</source>
<volume>516</volume>: <fpage>121</fpage>&#x02013;<lpage>125</lpage>, <year>2014</year><pub-id pub-id-type="pmid">25471886</pub-id></mixed-citation></ref><ref id="B54"><label>54</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Richardson</surname><given-names>JD</given-names></name></person-group> and <person-group person-group-type="author"><name><surname>Vasko</surname><given-names>MR</given-names></name></person-group>
<article-title>Cellular mechanisms of neurogenic inflammation</article-title>. <source>J Pharmacol Exp Ther</source>
<volume>302</volume>: <fpage>839</fpage>&#x02013;<lpage>845</lpage>, <year>2002</year><pub-id pub-id-type="pmid">12183638</pub-id></mixed-citation></ref><ref id="B55"><label>55</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rola</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Szulczyk</surname><given-names>PJ</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Witkowski</surname><given-names>G</given-names></name></person-group>
<article-title>Voltage-dependent Ca<sup>2+</sup> currents in rat cardiac dorsal root ganglion neurons</article-title>. <source>Brain Res</source>
<volume>961</volume>: <fpage>171</fpage>&#x02013;<lpage>178</lpage>, <year>2003</year><pub-id pub-id-type="pmid">12535791</pub-id></mixed-citation></ref><ref id="B56"><label>56</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Rose</surname><given-names>KE</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lunardi</surname><given-names>N</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Boscolo</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dong</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Erisir</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jevtovic-Todorovic</surname><given-names>V</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>
<article-title>Immunohistological demonstration of Ca<sub>V</sub>3.2 T-type voltage-gated calcium channel expression in soma of dorsal root ganglion neurons and peripheral axons of rat and mouse</article-title>. <source>Neuroscience</source>
<volume>250</volume>: <fpage>263</fpage>&#x02013;<lpage>274</lpage>, <year>2013</year><pub-id pub-id-type="pmid">23867767</pub-id></mixed-citation></ref><ref id="B57"><label>57</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sculptoreanu</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Aura Kullmann</surname><given-names>F</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>de Groat</surname><given-names>WC</given-names></name></person-group>
<article-title>Neurokinin 2 receptor-mediated activation of protein kinase C modulates capsaicin responses in DRG neurons from adult rats</article-title>. <source>Eur J Neurosci</source>
<volume>27</volume>: <fpage>3171</fpage>&#x02013;<lpage>3181</lpage>, <year>2008</year><pub-id pub-id-type="pmid">18598261</pub-id></mixed-citation></ref><ref id="B58"><label>58</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sculptoreanu</surname><given-names>A</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>de Groat</surname><given-names>WC</given-names></name></person-group>
<article-title>Protein kinase C is involved in neurokinin receptor modulation of N- and L-type Ca<sup>2+</sup> channels in DRG neurons of the adult rat</article-title>. <source>J Neurophysiol</source>
<volume>90</volume>: <fpage>21</fpage>&#x02013;<lpage>31</lpage>, <year>2003</year><pub-id pub-id-type="pmid">12660348</pub-id></mixed-citation></ref><ref id="B59"><label>59</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Sindrup</surname><given-names>SH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Graf</surname><given-names>A</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Sfikas</surname><given-names>N</given-names></name></person-group>
<article-title>The NK1-receptor antagonist TKA731 in painful diabetic neuropathy: A randomised, controlled trial</article-title>. <source>Eur J Pain</source>
<volume>10</volume>: <fpage>567</fpage>&#x02013;<lpage>571</lpage>, <year>2006</year><pub-id pub-id-type="pmid">16199188</pub-id></mixed-citation></ref><ref id="B60"><label>60</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Springer</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Groneberg</surname><given-names>DA</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dinh</surname><given-names>QT</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Quarcoo</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hamelmann</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Braun-Dullaeus</surname><given-names>RC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Geppetti</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Anker</surname><given-names>SD</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Fischer</surname><given-names>A</given-names></name></person-group>
<article-title>Neurokinin-1 receptor activation induces reactive oxygen species and epithelial damage in allergic airway inflammation</article-title>. <source>Clin Exp Allergy</source>
<volume>37</volume>: <fpage>1788</fpage>&#x02013;<lpage>1797</lpage>, <year>2007</year><pub-id pub-id-type="pmid">17941913</pub-id></mixed-citation></ref><ref id="B61"><label>61</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Stadtman</surname><given-names>ER</given-names></name></person-group>
<article-title>Protein oxidation in aging and age-related diseases</article-title>. <source>Ann N Y Acad Sci</source>
<volume>928</volume>: <fpage>22</fpage>&#x02013;<lpage>38</lpage>, <year>2001</year><pub-id pub-id-type="pmid">11795513</pub-id></mixed-citation></ref><ref id="B62"><label>62</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Steinhoff</surname><given-names>MS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>von Mentzer</surname><given-names>B</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Geppetti</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pothoulakis</surname><given-names>C</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Bunnett</surname><given-names>NW</given-names></name></person-group>
<article-title>Tachykinins and their receptors: Contributions to physiological control and the mechanisms of disease</article-title>. <source>Physiol Rev</source>
<volume>94</volume>: <fpage>265</fpage>&#x02013;<lpage>301</lpage>, <year>2014</year><pub-id pub-id-type="pmid">24382888</pub-id></mixed-citation></ref><ref id="B63"><label>63</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Talley</surname><given-names>EM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cribbs</surname><given-names>LL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lee</surname><given-names>JH</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Daud</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Bayliss</surname><given-names>DA</given-names></name></person-group>
<article-title>Differential distribution of three members of a gene family encoding low voltage-activated (T-type) calcium channels</article-title>. <source>J Neurosci</source>
<volume>19</volume>: <fpage>1895</fpage>&#x02013;<lpage>1911</lpage>, <year>1999</year><pub-id pub-id-type="pmid">10066243</pub-id></mixed-citation></ref><ref id="B64"><label>64</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tanabe</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Otani</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Bao</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mikami</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yasukura</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ninomiya</surname><given-names>T</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ogawa</surname><given-names>R</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Inagaki</surname><given-names>C</given-names></name></person-group>
<article-title>Intracellular signaling pathway of substance P-induced superoxide production in human neutrophils</article-title>. <source>Eur J Pharmacol</source>
<volume>299</volume>: <fpage>187</fpage>&#x02013;<lpage>195</lpage>, <year>1996</year><pub-id pub-id-type="pmid">8901022</pub-id></mixed-citation></ref><ref id="B65"><label>65</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Todorovic</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jevtovic-Todorovic</surname><given-names>V</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Meyenburg</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mennerick</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Perez-Reyes</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Romano</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Olney</surname><given-names>JW</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Zorumski</surname><given-names>CF</given-names></name></person-group>
<article-title>Redox modulation of T-type calcium channels in rat peripheral nociceptors</article-title>. <source>Neuron</source>
<volume>31</volume>: <fpage>75</fpage>&#x02013;<lpage>85</lpage>, <year>2001</year><pub-id pub-id-type="pmid">11498052</pub-id></mixed-citation></ref><ref id="B66"><label>66</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Traboulsie</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chemin</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chevalier</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Quignard</surname><given-names>JF</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Nargeot</surname><given-names>J</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Lory</surname><given-names>P</given-names></name></person-group>
<article-title>Subunit-specific modulation of T-type calcium channels by zinc</article-title>. <source>J Physiol</source>
<volume>578</volume>: <fpage>159</fpage>&#x02013;<lpage>171</lpage>, <year>2007</year><pub-id pub-id-type="pmid">17082234</pub-id></mixed-citation></ref><ref id="B67"><label>67</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Tringham</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Powell</surname><given-names>KL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cain</surname><given-names>SM</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kuplast</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mezeyova</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Weerapura</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Eduljee</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Smith</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Morrison</surname><given-names>JL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jones</surname><given-names>NC</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Braine</surname><given-names>E</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rind</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fee-Maki</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Parker</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pajouhesh</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Parmar</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>O'Brien</surname><given-names>TJ</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Snutch</surname><given-names>TP</given-names></name></person-group>
<article-title>T-type calcium channel blockers that attenuate thalamic burst firing and suppress absence seizures</article-title>. <source>Sci Transl Med</source>
<volume>4</volume>: <fpage>121ra19</fpage>, <year>2012</year></mixed-citation></ref><ref id="B68"><label>68</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Usoskin</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Furlan</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Islam</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Abdo</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lonnerberg</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lou</surname><given-names>D</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Hjerling-Leffler</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Haeggstrom</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kharchenko</surname><given-names>O</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kharchenko</surname><given-names>PV</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Linnarsson</surname><given-names>S</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Ernfors</surname><given-names>P</given-names></name></person-group>
<article-title>Unbiased classification of sensory neuron types by large-scale single-cell RNA sequencing</article-title>. <source>Nat Neurosci</source>
<volume>18</volume>: <fpage>145</fpage>&#x02013;<lpage>153</lpage>, <year>2015</year><pub-id pub-id-type="pmid">25420068</pub-id></mixed-citation></ref><ref id="B69"><label>69</label><mixed-citation publication-type="book"><person-group person-group-type="author"><name><surname>von Bohlen und Halbach</surname><given-names>O</given-names></name></person-group> and <person-group person-group-type="author"><name><surname>Dermietzel</surname><given-names>R</given-names></name></person-group>
<source>Neurotransmitters and Neuromediators. Handbook of Receptors and Biological Effects</source>. <publisher-loc>Weinheim</publisher-loc>: <publisher-name>Wiley-Vch Verlag Gmbh &#x00026; Co.</publisher-name>, <year>2006</year>, p. <fpage>386</fpage></mixed-citation></ref><ref id="B70"><label>70</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Fang</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Groom</surname><given-names>L</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cheng</surname><given-names>A</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Li</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Han</surname><given-names>P</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zheng</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Yin</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Mattson</surname><given-names>MP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kao</surname><given-names>JP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lakatta</surname><given-names>EG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sheu</surname><given-names>SS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ouyang</surname><given-names>K</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Chen</surname><given-names>J</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Dirksen</surname><given-names>RT</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Cheng</surname><given-names>H</given-names></name></person-group>
<article-title>Superoxide flashes in single mitochondria</article-title>. <source>Cell</source>
<volume>134</volume>: <fpage>279</fpage>&#x02013;<lpage>290</lpage>, <year>2008</year><pub-id pub-id-type="pmid">18662543</pub-id></mixed-citation></ref><ref id="B71"><label>71</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Waxman</surname><given-names>SG</given-names></name></person-group> and <person-group person-group-type="author"><name><surname>Zamponi</surname><given-names>GW</given-names></name></person-group>
<article-title>Regulating excitability of peripheral afferents: Emerging ion channel targets</article-title>. <source>Nat Neurosci</source>
<volume>17</volume>: <fpage>153</fpage>&#x02013;<lpage>163</lpage>, <year>2014</year><pub-id pub-id-type="pmid">24473263</pub-id></mixed-citation></ref><ref id="B72"><label>72</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Weidner</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klede</surname><given-names>M</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Rukwied</surname><given-names>R</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lischetzki</surname><given-names>G</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Neisius</surname><given-names>U</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Skov</surname><given-names>PS</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Petersen</surname><given-names>LJ</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Schmelz</surname><given-names>M</given-names></name></person-group>
<article-title>Acute effects of substance P and calcitonin gene-related peptide in human skin &#x02013; A microdialysis study</article-title>. <source>J Invest Dermatol</source>
<volume>115</volume>: <fpage>1015</fpage>&#x02013;<lpage>1020</lpage>, <year>2000</year><pub-id pub-id-type="pmid">11121135</pub-id></mixed-citation></ref><ref id="B73"><label>73</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Cang</surname><given-names>CL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Kawasaki</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liang</surname><given-names>LL</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zhang</surname><given-names>YQ</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Ji</surname><given-names>RR</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Zhao</surname><given-names>ZQ</given-names></name></person-group>
<article-title>Neurokinin-1 receptor enhances TRPV1 activity in primary sensory neurons via PKCepsilon: A novel pathway for heat hyperalgesia</article-title>. <source>J Neurosci</source>
<volume>27</volume>: <fpage>12067</fpage>&#x02013;<lpage>12077</lpage>, <year>2007</year><pub-id pub-id-type="pmid">17978048</pub-id></mixed-citation></ref><ref id="B74"><label>74</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Pietra</surname><given-names>C</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Lovati</surname><given-names>E</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>de Groat</surname><given-names>WC</given-names></name></person-group>
<article-title>Activation of neurokinin-1 receptors increases the excitability of guinea pig dorsal root ganglion cells</article-title>. <source>J Pharmacol Exp Ther</source>
<volume>343</volume>: <fpage>44</fpage>&#x02013;<lpage>52</lpage>, <year>2012</year><pub-id pub-id-type="pmid">22736506</pub-id></mixed-citation></ref><ref id="B75"><label>75</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname><given-names>Y</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Qin</surname><given-names>W</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Qian</surname><given-names>Z</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Liu</surname><given-names>X</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Wang</surname><given-names>H</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Gong</surname><given-names>S</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Sun</surname><given-names>YG</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Snutch</surname><given-names>TP</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Jiang</surname><given-names>X</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Tao</surname><given-names>J</given-names></name></person-group>
<article-title>Peripheral pain is enhanced by insulin-like growth factor 1 through a G protein-mediated stimulation of T-type calcium channels</article-title>. <source>Sci Signal</source>
<volume>7</volume>: <fpage>ra94</fpage>, <year>2014</year><pub-id pub-id-type="pmid">25292213</pub-id></mixed-citation></ref><ref id="B76"><label>76</label><mixed-citation publication-type="journal"><person-group person-group-type="author"><name><surname>Zorov</surname><given-names>DB</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Filburn</surname><given-names>CR</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Klotz</surname><given-names>LO</given-names></name></person-group>, <person-group person-group-type="author"><name><surname>Zweier</surname><given-names>JL</given-names></name></person-group>, and <person-group person-group-type="author"><name><surname>Sollott</surname><given-names>SJ</given-names></name></person-group>
<article-title>Reactive oxygen species (ROS)-induced ROS release: A new phenomenon accompanying induction of the mitochondrial permeability transition in cardiac myocytes</article-title>. <source>J Exp Med</source>
<volume>192</volume>: <fpage>1001</fpage>&#x02013;<lpage>1014</lpage>, <year>2000</year><pub-id pub-id-type="pmid">11015441</pub-id></mixed-citation></ref></ref-list><glossary><title>Abbreviations Used</title><def-list><def-item><term id="G1">ANOVA</term><def><p>analysis of variance</p></def></def-item><def-item><term id="G2">AP</term><def><p>action potential</p></def></def-item><def-item><term id="G3">AS</term><def><p>antisense</p></def></def-item><def-item><term id="G4">BIM I</term><def><p>bisindolylmaleimide I</p></def></def-item><def-item><term id="G5">BK</term><def><p>bradykinin</p></def></def-item><def-item><term id="G6">CNS</term><def><p>central nervous system</p></def></def-item><def-item><term id="G7">CP-99994</term><def><p>(2S,3S)-3-(2-Methoxybenzylamino)-2-phenylpiperidine dihydrochloride</p></def></def-item><def-item><term id="G8">DMEM</term><def><p>Dulbecco's modified Eagle medium</p></def></def-item><def-item><term id="G9">DRG</term><def><p>dorsal root ganglion</p></def></def-item><def-item><term id="G10">DTT</term><def><p>dithiothreitol</p></def></def-item><def-item><term id="G11">E<sub>rest</sub></term><def><p>resting membrane potential</p></def></def-item><def-item><term id="G12">ETC</term><def><p>electron transport chain</p></def></def-item><def-item><term id="G13">H<sub>2</sub>S</term><def><p>hydrogen sulfide</p></def></def-item><def-item><term id="G14">HEK</term><def><p>human embryonic kidney</p></def></def-item><def-item><term id="G15">HVA</term><def><p>high-voltage activated</p></def></def-item><def-item><term id="G16">LVA</term><def><p>low-voltage activated</p></def></def-item><def-item><term id="G17">MIB</term><def><p>mibefradil</p></def></def-item><def-item><term id="G18">mRNA</term><def><p>messenger RNA</p></def></def-item><def-item><term id="G19">NK</term><def><p>neurokinin</p></def></def-item><def-item><term id="G20">ODN</term><def><p>oligodeoxynucleotide</p></def></def-item><def-item><term id="G21">PTX</term><def><p>pertussis toxin</p></def></def-item><def-item><term id="G22">ROS</term><def><p>reactive oxygen species</p></def></def-item><def-item><term id="G23">RTG</term><def><p>retigabine</p></def></def-item><def-item><term id="G24">RT-PCR</term><def><p>reverse transcription polymerase chain reaction</p></def></def-item><def-item><term id="G25">S9M11SP</term><def><p>[Sar<sup>9</sup>, Met(O<sub>2</sub>)<sup>11</sup>]-Substance P</p></def></def-item><def-item><term id="G26">S9SP</term><def><p>[Sar<sup>9</sup>]-Substance P</p></def></def-item><def-item><term id="G27">SP</term><def><p>substance P</p></def></def-item><def-item><term id="G28">ST101</term><def><p>spiro[imidazo[1,2-a]pyridine-3,2-indan]-2(3H)-one</p></def></def-item><def-item><term id="G29">TPEN</term><def><p>N,N,N&#x02032;,N&#x02032;<italic>-</italic>Tetrakis(2-pyridylmethyl)ethylenediamine</p></def></def-item><def-item><term id="G30">TRPV1</term><def><p>transient receptor potential cation channel subfamily V member 1</p></def></def-item><def-item><term id="G31">VGCC</term><def><p>voltage-gated Ca<sup>2+</sup> channel</p></def></def-item><def-item><term id="G32">Z944</term><def><p>N-[[1-[2-(tert-butylamino)-2-oxoethyl]piperidin-4-yl]methyl]-3-chloro-5-fluorobenzamide</p></def></def-item><def-item><term id="G33">ZnPy</term><def><p>zinc pyrithione</p></def></def-item></def-list></glossary></back></article>